(lp1
(dp2
S'cdsr_refcode'
p3
VSTD-Humphreys-2010
p4
sS'pmc_id'
p5
S'PMC2924332'
p6
sS'cdsr_filename'
p7
VCD009987 v. 2.4 Decentralising HIV treatment in lower- and middle-income countries.rm5
p8
sS'pm_filename'
p9
V20687955.xml
p10
sa(dp11
g3
VSTD-Fatti-2010
p12
sg5
S'PMC2943483'
p13
sg7
g8
sg9
V20877631.xml
p14
sa(dp15
g3
VSTD-Jaffar-2009
p16
sg5
S'PMC2806484'
p17
sg7
g8
sg9
V19939445.xml
p18
sa(dp19
g3
VSTD-Lannin-2007
p20
sg5
S'PMC1832184'
p21
sg7
VCD007146 v. 8.0 Interventions for preventing falls in older people living in the community.rm5
p22
sg9
V17355644.xml
p23
sa(dp24
g3
VSTD-Spink-2011
p25
sg5
S'PMC3116775'
p26
sg7
g22
sg9
V21680622.xml
p27
sa(dp28
g3
VSTD-Haran-2010
p29
sg5
S'PMC2876235'
p30
sg7
g22
sg9
V20501583.xml
p31
sa(dp32
g3
VSTD-Conroy-2010
p33
sg5
S'PMC2956530'
p34
sg7
g22
sg9
V20823124.xml
p35
sa(dp36
g3
VSTD-Dangour-2011
p37
sg5
S'PMC3079648'
p38
sg7
g22
sg9
V21526229.xml
p39
sa(dp40
g3
VSTD-Logan-2010
p41
sg5
S'PMC2868162'
p42
sg7
g22
sg9
V20460331.xml
p43
sa(dp44
g3
VSTD-Nilforoushzadeh-2007
p45
sg5
S'PMC1891315'
p46
sg7
VCD005067 v. 6.0 Interventions for Old World cutaneous leishmaniasis.rm5
p47
sg9
V17466071.xml
p48
sa(dp49
g3
VSTD-Papasavvas-2004
p50
sg5
S'PMC539050'
p51
sg7
VCD005482 v. 4.0 Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.rm5
p52
sg9
V15630469.xml
p53
sa(dp54
g3
VSTD-Hager-1996
p55
sg5
S'PMC2364471'
p56
sg7
VCD005458 v. 6.0 Antibiotics for mastitis in breastfeeding women.rm5
p57
sg9
V18476075.xml
p58
sa(dp59
g3
VSTD-Catani-2009
p60
sg5
S'PMC2685130'
p61
sg7
VCD006726 v. 4.0 Psychological therapies for the treatment of post-traumatic stress disorder in children and adolesce.rm5
p62
sg9
V19439099.xml
p63
sa(dp64
g3
VSTD-Haran-2010
p65
sg5
S'PMC2876235'
p66
sg7
VCD008728 v. 2.0 Interventions for preventing falls in people after stroke.rm5
p67
sg9
V20501583.xml
p68
sa(dp69
g3
VSTD-Elliott-2005
p70
sg5
S'PMC1352364'
p71
sg7
VCD005547 v. 5.0 Effect of administration of antihelminthics for soil transmitted helminths during pregnancy.rm5
p72
sg9
V16371154.xml
p73
sa(dp74
g3
VSTD-Selby-1989
p75
sg5
S'PMC2247066'
p76
sg7
VCD006706 v. 2.0 Interventions for the prevention and treatment of herpes simplex virus in patients being treated for.rm5
p77
sg9
V2539180.xml
p78
sa(dp79
g3
VSTD-Anderson-1984
p80
sg5
S'PMC1976928'
p81
sg7
g77
sg9
V6378236.xml
p82
sa(dp83
g3
VSTD-Noyes-1998
p84
sg5
S'PMC1784814'
p85
sg7
VCD008726 v. 1.0 Different classes of antibiotics given to women routinely for preventing infection at caesarean sect.rm5
p86
sg9
V9894177.xml
p87
sa(dp88
g3
VSTD-Finsen-2006
p89
sg5
S'PMC1459867'
p90
sg7
VMR000008 v. 7.0 Methods to increase response to postal and electronic questionnaires.rm5
p91
sg9
V16646970.xml
p92
sa(dp93
g3
VSTD-Cockayne-2005
p94
sg5
S'PMC1280926'
p95
sg7
g91
sg9
V16250910.xml
p96
sa(dp97
g3
VSTD-Roberts-2004
p98
sg5
S'PMC534094'
p99
sg7
g91
sg9
V15533256.xml
p100
sa(dp101
g3
VSTD-McKenzie_x002d_McHarg-2005
p102
sg5
S'PMC1190172'
p103
sg7
g91
sg9
V16091137.xml
p104
sa(dp105
g3
VSTD-Kenyon-2005
p106
sg5
S'PMC1201139'
p107
sg7
g91
sg9
V16109160.xml
p108
sa(dp109
g3
VSTD-Br_x00f8_gger-2007
p110
sg5
S'PMC2270416'
p111
sg7
g91
sg9
V18174120.xml
p112
sa(dp113
g3
VSTD-Lavelle-2008
p114
sg5
S'PMC2427026'
p115
sg7
g91
sg9
V18507819.xml
p116
sa(dp117
g3
VSTD-Harrison-2004
p118
sg5
S'PMC534787'
p119
sg7
g91
sg9
V15537429.xml
p120
sa(dp121
g3
VSTD-Moses-2004
p122
sg5
S'PMC449720'
p123
sg7
g91
sg9
V15222889.xml
p124
sa(dp125
g3
VSTD-Clark-TJ-2001
p126
sg5
S'PMC64502'
p127
sg7
g91
sg9
V11782286.xml
p128
sa(dp129
g3
VSTD-Body-2004
p130
sg5
S'PMC2409647'
p131
sg7
VCD003474 v. 15.3 Bisphosphonates and other bone agents for breast cancer.rm5
p132
sg9
V15026791.xml
p133
sa(dp134
g3
VSTD-Ziboh-2004
p135
sg5
S'PMC2275406'
p136
sg7
VCD005989 v. 4.0 Herbal interventions for chronic asthma in adults and children.rm5
p137
sg9
V15154607.xml
p138
sa(dp139
g3
VSTD-Fridkin-2002
p140
sg5
S'PMC3369588'
p141
sg7
VCD003543 v. 10.0 Interventions to improve antibiotic prescribing practices for hospital inpatients.rm5
p142
sg9
V12095438.xml
p143
sa(dp144
g3
VSTD-Luabeya-2007
p145
sg5
S'PMC1891438'
p146
sg7
VCD003650 v. 8.0 Micronutrient supplementation in children and adults with HIV infection.rm5
p147
sg9
V17593956.xml
p148
sa(dp149
g3
VSTD-Del-Romero-2010
p150
sg5
S'PMC2871073'
p151
sg7
VCD009153 v. 5.0 Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.rm5
p152
sg9
V20472675.xml
p153
sa(dp154
g3
VSTD-Tonwe_x002d_Gold-2007
p155
sg5
S'PMC1949842'
p156
sg7
VCD008440 v. 2.0 Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.rm5
p157
sg9
V17713983.xml
p158
sa(dp159
g3
VSTD-Domenge-2000
p160
sg5
S'PMC2363468'
p161
sg7
VCD006386 v. 4.0 Interventions for the treatment of oral cavity and oropharyngeal cancer chemotherapy.rm5
p162
sg9
V11189100.xml
p163
sa(dp164
g3
VSTD-UKHAN-2010
p165
sg5
S'PMC2806549'
p166
sg7
g162
sg9
V19875337.xml
p167
sa(dp168
g3
VSTD-Lenssen-2008
p169
sg5
S'PMC2386789'
p170
sg7
VCD008207 v. 2.0 Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.rm5
p171
sg9
V18442423.xml
p172
sa(dp173
g3
VSTD-Kerse-2008
p174
sg5
S'PMC2565754'
p175
sg7
VCD005465 v. 7.10 Interventions for preventing falls in older people in care facilities and hospitals.rm5
p176
sg9
V18845605.xml
p177
sa(dp178
g3
VSTD-Crotty-2004b
p179
sg5
S'PMC415557'
p180
sg7
g176
sg9
V15066200.xml
p181
sa(dp182
g3
VSTD-Stenvall-2007
p183
sg5
S'PMC1766476'
p184
sg7
g176
sg9
V17061151.xml
p185
sa(dp186
g3
VSTD-EPHT-2006
p187
sg5
S'PMC2330032'
p188
sg7
VCD004143 v. 6.0 Long term hormone therapy for perimenopausal and postmenopausal women.rm5
p189
sg9
V18366766.xml
p190
sa(dp191
g3
VSTD-Lauretti-2003
p192
sg5
S'PMC2376845'
p193
sg7
VCD003868 v. 11.0 Oral morphine for cancer pain.rm5
p194
sg9
V14647133.xml
p195
sa(dp196
g3
VSTD-Campos-2007
p197
sg5
S'PMC3476141'
p198
sg7
VCD000255 v. 8.0 Antithrombotic drugs for carotid artery dissection.rm5
p199
sg9
V17563840.xml
p200
sa(dp201
g3
VSTD-Rennard-2011
p202
sg5
S'PMC3281242'
p203
sg7
VCD006103 v. 12.0 Nicotine receptor partial agonists for smoking cessation.rm5
p204
sg9
V22080588.xml
p205
sa(dp206
g3
VSTD-Avasthi-2001
p207
sg5
S'PMC2956152'
p208
sg7
VCD001359 v. 12.0 Olanzapine for schizophrenia.rm5
p209
sg9
V21407865.xml
p210
sa(dp211
g3
VSTD-Becker-2010
p212
sg5
S'PMC2888216'
p213
sg7
VCD008653 v. 2.0 Febuxostat for treating chronic gout.rm5
p214
sg9
V20370912.xml
p215
sa(dp216
g3
VSTD-Curtis-2007
p217
sg5
S'PMC1950500'
p218
sg7
VCD006275 v. 11.0 Non-pharmacological management of infant and young child procedural pain.rm5
p219
sg9
V17640375.xml
p220
sa(dp221
g3
VSTD-Elserafy-2009
p222
sg5
S'PMC2813645'
p223
sg7
g219
sg9
V19448377.xml
p224
sa(dp225
g3
VSTD-Dobbins-2009
p226
sg5
S'PMC2936828'
p227
sg7
VCD009401 v. 3.3 Interventions to improve the use of systematic reviews in decision-making by health system managers.rm5
p228
sg9
V19775439.xml
p229
sa(dp230
g3
VSTD-Rutten_x002d_van-Molken-2007
p231
sg5
S'PMC1913175'
p232
sg7
VCD009157 v. 4.0 Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.rm5
p233
sg9
V17370096.xml
p234
sa(dp235
g3
VSTD-Ethgen-2009
p236
sg5
S'PMC2679061'
p237
sg7
VMR000030 v. 3.0 Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised.rm5
p238
sg9
V19358717.xml
p239
sa(dp240
g3
VSTD-Yu-2010
p241
sg5
S'PMC2886040'
p242
sg7
g238
sg9
V20482769.xml
p243
sa(dp244
g3
VSTD-Hopewell-2010
p245
sg5
S'PMC2844941'
p246
sg7
g238
sg9
V20332510.xml
p247
sa(dp248
g3
VSTD-Partsinevelou-2009
p249
sg5
S'PMC2788535'
p250
sg7
g238
sg9
V19930576.xml
p251
sa(dp252
g3
VSTD-Prady-2008
p253
sg5
S'PMC2216683'
p254
sg7
g238
sg9
V18270568.xml
p255
sa(dp256
g3
VSTD-Montan_x00e9_-2010
p257
sg5
S'PMC2822812'
p258
sg7
g238
sg9
V20067642.xml
p259
sa(dp260
g3
VSTD-Senkus_x002d_Konefka-2005
p261
sg5
S'PMC2361948'
p262
sg7
VCD002143 v. 12.0 Palliative radiotherapy regimens for non-small cell lung cancer.rm5
p263
sg9
V15770205.xml
p264
sa(dp265
g3
VSTD-MRC-1992
p266
sg5
S'PMC1977779'
p267
sg7
g263
sg9
V1377484.xml
p268
sa(dp269
g3
VSTD-Frankel-2010
p270
sg5
S'PMC2890979'
p271
sg7
VCD008511 v. 3.0 Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD).rm5
p272
sg9
V20058059.xml
p273
sa(dp274
g3
VSTD-Brown-2001
p275
sg5
S'PMC2375236'
p276
sg7
VCD003267 v. 6.2 Interventions for providers to promote a patient-centred approach in clinical consultations.rm5
p277
sg9
V11720460.xml
p278
sa(dp279
g3
VSTD-Florence-2011
p280
sg5
S'PMC3116927'
p281
sg7
VCD007825 v. 8.0 Collaboration between local health and local government agencies for health improvement.rm5
p282
sg9
V21680632.xml
p283
sa(dp284
g3
VSTD-ENGAGE-2009
p285
sg5
S'PMC2777786'
p286
sg7
VCD009577 v. 2.0 Long-acting FSH versus daily FSH for women undergoing assisted reproduction.rm5
p287
sg9
V19684043.xml
p288
sa(dp289
g3
VSTD-Howden_x002d_Chapman-2008
p290
sg5
S'PMC2658826'
p291
sg7
VCD008657 v. 3.0 Housing improvements for health and associated socio-economic outcomes.rm5
p292
sg9
V18812366.xml
p293
sa(dp294
g3
VSTD-Nishimoto-2009-_x0028_SATORI_x0029_
p295
sg5
S'PMC2638601'
p296
sg7
VCD008331 v. 2.0 Tocilizumab for rheumatoid arthritis.rm5
p297
sg9
V18979150.xml
p298
sa(dp299
g3
VSTD-Driver-2011-age-matched
p300
sg5
S'PMC3023971'
p301
sg7
VCD008454 v. 2.0 Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease evidence .rm5
p302
sg9
V21252104.xml
p303
sa(dp304
g3
VSTD-Driver-2011-age_x002b_-matched
p305
sg5
S'PMC3023971'
p306
sg7
g302
sg9
V21252104.xml
p307
sa(dp308
g3
VSTD-Burton-2006
p309
sg5
S'PMC3216418'
p310
sg7
VCD003189 v. 13.2 Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.rm5
p311
sg9
V16508640.xml
p312
sa(dp313
g3
VSTD-Rafati-2011
p314
sg5
S'PMC3232099'
p315
sg7
VCD009118 v. 2.0 Osmotic and stimulant laxatives for the management of childhood constipation.rm5
p316
sg9
V22615652.xml
p317
sa(dp318
g3
VSTD-Rachow-2011
p319
sg5
S'PMC3126807'
p320
sg7
VCD009593 v. 3.3 Xpert MTBRIF assay for pulmonary tuberculosis and rifampicin resistance in adults.rm5
p321
sg9
V21738575.xml
p322
sa(dp323
g3
VSTD-Scott-2011
p324
sg5
S'PMC3144192'
p325
sg7
g321
sg9
V21814495.xml
p326
sa(dp327
g3
VSTD-Boehme-2011f
p328
sg5
S'PMC3085933'
p329
sg7
g321
sg9
V21507477.xml
p330
sa(dp331
g3
VSTD-Boehme-2011e
p332
sg5
S'PMC3085933'
p333
sg7
g321
sg9
V21507477.xml
p334
sa(dp335
g3
VSTD-Boehme-2011d
p336
sg5
S'PMC3085933'
p337
sg7
g321
sg9
V21507477.xml
p338
sa(dp339
g3
VSTD-Boehme-2011c
p340
sg5
S'PMC3085933'
p341
sg7
g321
sg9
V21507477.xml
p342
sa(dp343
g3
VSTD-Boehme-2011b
p344
sg5
S'PMC3085933'
p345
sg7
g321
sg9
V21507477.xml
p346
sa(dp347
g3
VSTD-Boehme-2011a
p348
sg5
S'PMC3085933'
p349
sg7
g321
sg9
V21507477.xml
p350
sa(dp351
g3
VSTD-Lawn-2011
p352
sg5
S'PMC3144215'
p353
sg7
g321
sg9
V21818180.xml
p354
sa(dp355
g3
VSTD-Pakasi-2010
p356
sg5
S'PMC2957385'
p357
sg7
VCD006086 v. 4.2 Nutritional supplements for people being treated for active tuberculosis.rm5
p358
sg9
V20920186.xml
p359
sa(dp360
g3
VSTD-Martins-2009
p361
sg5
S'PMC2767482'
p362
sg7
g358
sg9
V19858174.xml
p363
sa(dp364
g3
VSTD-Johansson-2008
p365
sg5
S'PMC2607225'
p366
sg7
VCD007064 v. 4.6 Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed.rm5
p367
sg9
V19018255.xml
p368
sa(dp369
g3
VSTD-Ghorbani-2009
p370
sg5
S'PMC2847809'
p371
sg7
VCD008834 v. 3.0 Antiplatelet agents for chronic kidney disease.rm5
p372
sg9
V20368925.xml
p373
sa(dp374
g3
VSTD-Eriksen-1997
p375
sg5
S'PMC2364551'
p376
sg7
VCD004070 v. 8.0 Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group.rm5
p377
sg9
V18476153.xml
p378
sa(dp379
g3
VSTD-Katsourakis-2010
p380
sg5
S'PMC3108665'
p381
sg7
VCD008370 v. 5.0 Somatostatin analogues for pancreatic surgery.rm5
p382
sg9
V21694864.xml
p383
sa(dp384
g3
VSTD-Cornuz-2008
p385
sg5
S'PMC2432028'
p386
sg7
VCD007072 v. 4.0 Nicotine vaccines for smoking cessation.rm5
p387
sg9
V18575629.xml
p388
sa(dp389
g3
VSTD-Ricca-2007
p390
sg5
S'PMC3015793'
p391
sg7
VCD001546 v. 7.0 Laparoscopic versus open surgery for suspected appendicitis.rm5
p392
sg9
V17663093.xml
p393
sa(dp394
g3
VSTD-Ataoglu-2003
p395
sg5
S'PMC3055095'
p396
sg7
VCD005331 v. 4.0 Psychosocial interventions for conversion disorder.rm5
p397
sg9
V12923337.xml
p398
sa(dp399
g3
VSTD-Ettinger-2009
p400
sg5
S'PMC2627861'
p401
sg7
VCD007079 v. 2.0 Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy.rm5
p402
sg9
V19165383.xml
p403
sa(dp404
g3
VSTD-Yeboah_x002d_Antwi-2010
p405
sg5
S'PMC2943441'
p406
sg7
VCD009527 v. 2.0 Home- or community-based programmes for treating malaria.rm5
p407
sg9
V20877714.xml
p408
sa(dp409
g3
VSTD-Kouyate-2008
p410
sg5
S'PMC2287184'
p411
sg7
g407
sg9
V18364043.xml
p412
sa(dp413
g3
VSTD-Mubi-2011
p414
sg5
S'PMC3130036'
p415
sg7
g407
sg9
V21750697.xml
p416
sa(dp417
g3
VSTD-Kangwana-2011
p418
sg5
S'PMC3104978'
p419
sg7
g407
sg9
V21655317.xml
p420
sa(dp421
g3
VSTD-Akhter-2009
p422
sg5
S'PMC2695684'
p423
sg7
VCD009350 v. 2.0 Dietary flavonoid for preventing colorectal neoplasms.rm5
p424
sg9
V19417743.xml
p425
sa(dp426
g3
VSTD-Channabasavanna-1987
p427
sg5
S'PMC3172444'
p428
sg7
VCD002923 v. 11.0 Penfluridol for schizophrenia.rm5
p429
sg9
V21927264.xml
p430
sa(dp431
g3
VSTD-Smith-2010
p432
sg5
S'PMC2965151'
p433
sg7
VCD001865 v. 8.4 Personalised risk communication for informed decision making about taking screening tests.rm5
p434
sg9
V20978060.xml
p435
sa(dp436
g3
VSTD-Steckelberg-2011
p437
sg5
S'PMC3106362'
p438
sg7
g434
sg9
V21636633.xml
p439
sa(dp440
g3
VSTD-Vadillo_x002d_Ortega-2011
p441
sg5
S'PMC3100912'
p442
sg7
VCD004905 v. 7.3 Multiple-micronutrient supplementation for women during pregnancy.rm5
p443
sg9
V21596735.xml
p444
sa(dp445
g3
VSTD-Zeng-2008
p446
sg5
S'PMC2577799'
p447
sg7
g443
sg9
V18996930.xml
p448
sa(dp449
g3
VSTD-Fry-2003
p450
sg5
S'PMC2376929'
p451
sg7
VCD003721 v. 7.2 Cancer genetic risk assessment for individuals at risk of familial breast cancer.rm5
p452
sg9
V12915873.xml
p453
sa(dp454
g3
VSTD-Young-2006
p455
sg5
S'PMC2360713'
p456
sg7
g452
sg9
V17047645.xml
p457
sa(dp458
g3
VSTD-Osman-2008
p459
sg5
S'PMC2922723'
p460
sg7
VCD007862 v. 4.2 Active cycle of breathing technique for cystic fibrosis.rm5
p461
sg9
V19703826.xml
p462
sa(dp463
g3
VSTD-Ataoglu-2003
p464
sg5
S'PMC3055095'
p465
sg7
VCD006370 v. 5.0 Behavioural treatments for non-epileptic attack disorder.rm5
p466
sg9
V12923337.xml
p467
sa(dp468
g3
VSTD-Priotto-2006
p469
sg5
S'PMC1687208'
p470
sg7
VCD006201 v. 5.0 Chemotherapy for second-stage Human African trypanosomiasis.rm5
p471
sg9
V17160135.xml
p472
sa(dp473
g3
VSTD-Benn-2010
p474
sg5
S'PMC2835853'
p475
sg7
VCD006980 v. 5.0 Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in.rm5
p476
sg9
V20215360.xml
p477
sa(dp478
g3
VSTD-Hoddinott-2009
p479
sg5
S'PMC2635594'
p480
sg7
VCD001141 v. 9.4 Support for healthy breastfeeding mothers with healthy term babies.rm5
p481
sg9
V19181729.xml
p482
sa(dp483
g3
VSTD-Corbett-2006
p484
sg5
S'PMC1483908'
p485
sg7
VCD005274 v. 5.2 Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupation.rm5
p486
sg9
V16796402.xml
p487
sa(dp488
g3
VSTD-Coskun-2011
p489
sg5
S'PMC3109380'
p490
sg7
VCD004829 v. 5.2 Pain relief for women undergoing oocyte retrieval for assisted reproduction.rm5
p491
sg9
V21789385.xml
p492
sa(dp493
g3
VSTD-Beran-2009a
p494
sg5
S'PMC2639595'
p495
sg7
VCD001269 v. 13.0 Vaccines for preventing influenza in healthy adults.rm5
p496
sg9
V19149900.xml
p497
sa(dp498
g3
VSTD-Varkey-2011
p499
sg5
S'PMC3236524'
p500
sg7
VCD010610 v. 1.2 Topiramate for the prophylaxis of episodic migraine in adults.rm5
p501
sg9
V21890526.xml
p502
sa(dp503
g3
VSTD-Bahadoran-2010
p504
sg5
S'PMC3208940'
p505
sg7
VCD007426 v. 3.0 Relaxation therapy for preventing and treating preterm labour.rm5
p506
sg9
V22069407.xml
p507
sa(dp508
g3
VSTD-Bertleff-2009
p509
sg5
S'PMC2691927'
p510
sg7
VCD004778 v. 7.0 Laparoscopic repair for perforated peptic ulcer disease.rm5
p511
sg9
V19430829.xml
p512
sa(dp513
g3
VSTD-Chen-2009
p514
sg5
S'PMC2666722'
p515
sg7
VCD006207 v. 9.1 Physical interventions to interrupt or reduce the spread of respiratory viruses.rm5
p516
sg9
V19284644.xml
p517
sa(dp518
g3
VSTD-Cowling-2008
p519
sg5
S'PMC2364646'
p520
sg7
g516
sg9
V18461182.xml
p521
sa(dp522
g3
VSTD-Wu-2004
p523
sg5
S'PMC3322931'
p524
sg7
g516
sg9
V15030685.xml
p525
sa(dp526
g3
VSTD-MacIntyre-2009
p527
sg5
S'PMC2662657'
p528
sg7
g516
sg9
V19193267.xml
p529
sa(dp530
g3
VSTD-Lau-2004a
p531
sg5
S'PMC3323085'
p532
sg7
g516
sg9
V15200846.xml
p533
sa(dp534
g3
VSTD-Cowling-2010
p535
sg5
S'PMC3152767'
p536
sg7
g516
sg9
V20353566.xml
p537
sa(dp538
g3
VSTD-Psaradellis-2010
p539
sg5
S'PMC3278944'
p540
sg7
VCD006095 v. 3.0 Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.rm5
p541
sg9
V22371721.xml
p542
sa(dp543
g3
VSTD-Atzpodien-2002
p544
sg5
S'PMC2375173'
p545
sg7
VCD005413 v. 4.0 Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.rm5
p546
sg9
V11870502.xml
p547
sa(dp548
g3
VSTD-Johnston-1998
p549
sg5
S'PMC2150174'
p550
sg7
g546
sg9
V9579834.xml
p551
sa(dp552
g3
VSTD-Shepherd-1998
p553
sg5
S'PMC2063048'
p554
sg7
VCD004699 v. 7.0 Surgery for local and locally advanced non-small cell lung cancer.rm5
p555
sg9
V9744511.xml
p556
sa(dp557
g3
VSTD-Lin-2005
p558
sg5
S'PMC1550679'
p559
sg7
VCD007978 v. 3.0 Email for clinical communication between patientscaregivers and healthcare professionals.rm5
p560
sg9
V16236699.xml
p561
sa(dp562
g3
VSTD-Ross-2004
p563
sg5
S'PMC1550594'
p564
sg7
g560
sg9
V15249261.xml
p565
sa(dp566
g3
VSTD-Gentile-2009
p567
sg5
S'PMC2758893'
p568
sg7
VCD001871 v. 13.12 Interventions for preventing obesity in children.rm5
p569
sg9
V19765270.xml
p570
sa(dp571
g3
VSTD-Lazaar-2007
p572
sg5
S'PMC2040215'
p573
sg7
g569
sg9
V17718785.xml
p574
sa(dp575
g3
VSTD-Rosenberg-2007
p576
sg5
S'PMC1964758'
p577
sg7
VCD006188 v. 3.0 Surgical interventions for the rheumatoid shoulder.rm5
p578
sg9
V17683577.xml
p579
sa(dp580
g3
VSTD-Crotty-2004
p581
sg5
S'PMC415557'
p582
sg7
VCD000409 v. 7.0 Educational outreach visits effects on professional practice and health care outcomes.rm5
p583
sg9
V15066200.xml
p584
sa(dp585
g3
VSTD-Fretheim-2006
p586
sg5
S'PMC1472698'
p587
sg7
g583
sg9
V16737349.xml
p588
sa(dp589
g3
VSTD-Schultz-2004
p590
sg5
S'PMC394324'
p591
sg7
VCD004826 v. 5.0 Probiotics for maintenance of remission in Crohn's disease.rm5
p592
sg9
V15113451.xml
p593
sa(dp594
g3
VSTD-Callaway-2010
p595
sg5
S'PMC2890340'
p596
sg7
VCD009021 v. 2.0 Exercise for pregnant women for preventing gestational diabetes mellitus.rm5
p597
sg9
V20357374.xml
p598
sa(dp599
g3
VSTD-Callaway-2010
p600
sg5
S'PMC2890340'
p601
sg7
VCD007145 v. 2.0 Interventions for preventing excessive weight gain during pregnancy.rm5
p602
sg9
V20357374.xml
p603
sa(dp604
g3
VSTD-Korpi_x002d_Hyovalti-2011
p605
sg5
S'PMC3078095'
p606
sg7
g602
sg9
V21429234.xml
p607
sa(dp608
g3
VSTD-Moses-2009
p609
sg5
S'PMC2681032'
p610
sg7
g602
sg9
V19279301.xml
p611
sa(dp612
g3
VSTD-Luoto-2011
p613
sg5
S'PMC3096610'
p614
sg7
g602
sg9
V21610860.xml
p615
sa(dp616
g3
VSTD-Ott-1998
p617
sg5
S'PMC3015252'
p618
sg7
VCD007821 v. 2.0 Heated CO2 with or without humidification for minimally invasive abdominal surgery.rm5
p619
sg9
V10036122.xml
p620
sa(dp621
g3
VSTD-Scott-2002
p622
sg5
S'PMC1784606'
p623
sg7
VCD004946 v. 4.0 Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) rec.rm5
p624
sg9
V12530483.xml
p625
sa(dp626
g3
VSTD-Boogaerts-2003
p627
sg5
S'PMC2376376'
p628
sg7
VCD007303 v. 3.2 Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient d.rm5
p629
sg9
V12671693.xml
p630
sa(dp631
g3
VSTD-Wilkinson-2006
p632
sg5
S'PMC2361228'
p633
sg7
g629
sg9
V16570051.xml
p634
sa(dp635
g3
VSTD-Benn-2010
p636
sg5
S'PMC2835853'
p637
sg7
VCD007480 v. 2.0 Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age.rm5
p638
sg9
V20215360.xml
p639
sa(dp640
g3
VSTD-Moorthy-2004b
p641
sg5
S'PMC524376'
p642
sg7
VCD006198 v. 3.0 Vaccines for preventing malaria (pre-erythrocytic).rm5
p643
sg9
V15526058.xml
p644
sa(dp645
g3
VSTD-P_x00e9_rez_x002d_B_x00e1_rcena-2008
p646
sg5
S'PMC2575601'
p647
sg7
VCD000033 v. 9.12 Barbiturates for acute traumatic brain injury.rm5
p648
sg9
V18759980.xml
p649
sa(dp650
g3
VSTD-Ko-2009
p651
sg5
S'PMC2650992'
p652
sg7
VCD009557 v. 2.0 Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and a.rm5
p653
sg9
V19270819.xml
p654
sa(dp655
g3
VSTD-Meyer-2008
p656
sg5
S'PMC2253708'
p657
sg7
VCD004492 v. 9.0 Stage-based interventions for smoking cessation.rm5
p658
sg9
V17995993.xml
p659
sa(dp660
g3
VSTD-Young-2008
p661
sg5
S'PMC2268921'
p662
sg7
g658
sg9
V18304363.xml
p663
sa(dp664
g3
VSTD-Awasthi-2008-_x0028_Cluster_x0029_
p665
sg5
S'PMC2291568'
p666
sg7
VCD000371 v. 15.4 Deworming drugs for soil-transmitted intestinal worms in children effects on nutritional indicators.rm5
p667
sg9
V18414647.xml
p668
sa(dp669
g3
VSTD-Kirwan-2010
p670
sg5
S'PMC3161357'
p671
sg7
g667
sg9
V20858280.xml
p672
sa(dp673
g3
VSTD-Narvekar-2010
p674
sg5
S'PMC2890904'
p675
sg7
VCD009517 v. 2.6 Endometrial injury in women undergoing assisted reproductive techniques.rm5
p676
sg9
V20607003.xml
p677
sa(dp678
g3
VSTD-_x005e_Horst-2005
p679
sg5
S'PMC2424122'
p680
sg7
VCD007253 v. 5.13 Interventions for smoking cessation and reduction in individuals with schizophrenia.rm5
p681
sg9
V18568115.xml
p682
sa(dp683
g3
VSTD-Ziegler-2010
p684
sg5
S'PMC2845038'
p685
sg7
VCD009318 v. 2.0 Lacosamide for neuropathic pain and fibromyalgia in adults.rm5
p686
sg9
V20067958.xml
p687
sa(dp688
g3
VSTD-Qu-2007
p689
sg5
S'PMC1810361'
p690
sg7
VCD009232 v. 2.0 Acupuncture or acupressure for pain management in labour.rm5
p691
sg9
V17342250.xml
p692
sa(dp693
g3
VSTD-Bouzari-2011
p694
sg5
S'PMC3217057'
p695
sg7
VCD009997 v. 1.0 Intermittent oral iron supplementation during pregnancy.rm5
p696
sg9
V22026956.xml
p697
sa(dp698
g3
VSTD-Yekta-2011
p699
sg5
S'PMC3233526'
p700
sg7
g696
sg9
V22162919.xml
p701
sa(dp702
g3
VSTD-Starobin-2007
p703
sg5
S'PMC1892551'
p704
sg7
VCD005566 v. 4.0 Prophylactic corticosteroids for cardiopulmonary bypass in adults.rm5
p705
sg9
V17547746.xml
p706
sa(dp707
g3
VSTD-Tan-2008
p708
sg5
S'PMC2780654'
p709
sg7
VCD006761 v. 5.0 Conventional versus LigaSure hemorrhoidectomy for patients with symptomatic Hemorrhoids.rm5
p710
sg9
V18545884.xml
p711
sa(dp712
g3
VSTD-Wamalwa-2009
p713
sg5
S'PMC2708138'
p714
sg7
VCD009513 v. 1.0 Interventions to improve adherence to antiretroviral therapy in children with HIV infection.rm5
p715
sg9
V19549342.xml
p716
sa(dp717
g3
VSTD-Patel-2009
p718
sg5
S'PMC2684117'
p719
sg7
VCD005436 v. 5.0 Oral zinc for treating diarrhoea in children.rm5
p720
sg9
V19416499.xml
p721
sa(dp722
g3
VSTD-Patel-2009a-_x0028_zinc_x0029_
p723
sg5
S'PMC2684117'
p724
sg7
g720
sg9
V19416499.xml
p725
sa(dp726
g3
VSTD-Patel-2009b-_x0028_zinc_x002b_copper_x0029_
p727
sg5
S'PMC2684117'
p728
sg7
g720
sg9
V19416499.xml
p729
sa(dp730
g3
VSTD-d-SGCTG-1986
p731
sg5
S'PMC1977737'
p732
sg7
VCD001418 v. 8.0 Chemotherapy for advanced ovarian cancer.rm5
p733
sg9
V1739629.xml
p734
sa(dp735
g3
VSTD-Meyer-2008
p736
sg5
S'PMC2253708'
p737
sg7
VCD000165 v. 14.0 Physician advice for smoking cessation.rm5
p738
sg9
V17995993.xml
p739
sa(dp740
g3
VSTD-Unrod-2007
p741
sg5
S'PMC1829425'
p742
sg7
g738
sg9
V17372796.xml
p743
sa(dp744
g3
VSTD-Lalit-2004
p745
sg5
S'PMC2950952'
p746
sg7
VCD006534 v. 4.0 Citalopram versus other anti-depressive agents for depression.rm5
p747
sg9
V21206792.xml
p748
sa(dp749
g3
VSTD-Windbichler-2000
p750
sg5
S'PMC2363351'
p751
sg7
VCD009620 v. 2.0 Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.rm5
p752
sg9
V10735496.xml
p753
sa(dp754
g3
VSTD-Hall-2004
p755
sg5
S'PMC2364769'
p756
sg7
g752
sg9
V15305182.xml
p757
sa(dp758
g3
VSTD-Kalilani-2007
p759
sg5
S'PMC2048661'
p760
sg7
VCD004912 v. 5.0 Drugs for treating uncomplicated malaria in pregnant women.rm5
p761
sg9
V18000538.xml
p762
sa(dp763
g3
VSTD-Coulibaly-2006
p764
sg5
S'PMC1533839'
p765
sg7
g761
sg9
V16776817.xml
p766
sa(dp767
g3
VSTD-Kasper-2006
p768
sg5
S'PMC1538611'
p769
sg7
VCD000448 v. 10.0 St John's wort for major depression.rm5
p770
sg9
V16796730.xml
p771
sa(dp772
g3
VSTD-Horn-2007
p773
sg5
S'PMC1832131'
p774
sg7
VCD003289 v. 8.0 Tobacco cessation interventions for young people.rm5
p775
sg9
V17173716.xml
p776
sa(dp777
g3
VSTD-McKay-2009
p778
sg5
S'PMC2817867'
p779
sg7
VCD006317 v. 4.0 Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.rm5
p780
sg9
V20148084.xml
p781
sa(dp782
g3
VSTD-Kim-2011
p783
sg5
S'PMC3204557'
p784
sg7
g780
sg9
V22066097.xml
p785
sa(dp786
g3
VSTD-Gajdos-2010
p787
sg5
S'PMC2946956'
p788
sg7
VCD004873 v. 9.0 Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.rm5
p789
sg9
V20927359.xml
p790
sa(dp791
g3
VSTD-Zeng-2008-_x0028_C_x0029_
p792
sg5
S'PMC2577799'
p793
sg7
VCD004736 v. 7.0 Daily oral iron supplementation during pregnancy.rm5
p794
sg9
V18996930.xml
p795
sa(dp796
g3
VSTD-Faglia-2010
p797
sg5
S'PMC2890332'
p798
sg7
VCD002302 v. 5.0 Pressure-relieving interventions for treating diabetic foot ulcers.rm5
p799
sg9
V20357377.xml
p800
sa(dp801
g3
VSTD-MRC-LU11
p802
sg5
S'PMC2074683'
p803
sg7
VCD002142 v. 13.0 Postoperative radiotherapy for non-small cell lung cancer.rm5
p804
sg9
V8761382.xml
p805
sa(dp806
g3
VSTD-Faithfull-2001
p807
sg5
S'PMC2364007'
p808
sg7
VCD006953 v. 3.6 Psychosocial interventions for reducing fatigue during cancer treatment in adults.rm5
p809
sg9
V11747326.xml
p810
sa(dp811
g3
VSTD-de-Vries-2007a
p812
sg5
S'PMC1913177'
p813
sg7
VCD006438 v. 4.0 Open surgical procedures for incisional hernias.rm5
p814
sg9
V17372669.xml
p815
sa(dp816
g3
VSTD-Horita-2007
p817
sg5
S'PMC2409178'
p818
sg7
VCD003962 v. 6.0 Non-immunosuppressive treatment for IgA nephropathy.rm5
p819
sg9
V17497466.xml
p820
sa(dp821
g3
VSTD-Soltanian-2010
p822
sg5
S'PMC3302710'
p823
sg7
VCD010538 v. 2.0 Topical herbal therapies for treating osteoarthritis.rm5
p824
sg9
V22427772.xml
p825
sa(dp826
g3
VSTD-Castro-2008
p827
sg5
S'PMC2664121'
p828
sg7
VCD005654 v. 4.0 Pelvic floor muscle training versus no treatment or inactive control treatments for urinary incont.rm5
p829
sg9
V18719756.xml
p830
sa(dp831
g3
VSTD-Michaud-2005
p832
sg5
S'PMC2361644'
p833
sg7
VCD005195 v. 9.0 Selenium for preventing cancer.rm5
p834
sg9
V16175184.xml
p835
sa(dp836
g3
VSTD-ba-Kissling-2011
p837
sg5
S'PMC3216983'
p838
sg7
VCD004879 v. 9.0 Vaccines for preventing influenza in healthy children.rm5
p839
sg9
V22110695.xml
p840
sa(dp841
g3
VSTD-ba-Valenciano-2011
p842
sg5
S'PMC3019108'
p843
sg7
g839
sg9
V21379316.xml
p844
sa(dp845
g3
VSTD-ab-Mallory-2010
p846
sg5
S'PMC2966412'
p847
sg7
g839
sg9
V21060780.xml
p848
sa(dp849
g3
VSTD-Song-2006
p850
sg5
S'PMC2721929'
p851
sg7
VCD003193 v. 6.2 Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrom.rm5
p852
sg9
V17179687.xml
p853
sa(dp854
g3
VSTD-Chancellor-2008
p855
sg5
S'PMC2325270'
p856
sg7
g852
sg9
V18324952.xml
p857
sa(dp858
g3
VSTD-Bautmans-2005
p859
sg5
S'PMC1368976'
p860
sg7
VCD004294 v. 6.3 Physical rehabilitation for older people in long-term care.rm5
p861
sg9
V16372905.xml
p862
sa(dp863
g3
VSTD-Kerse-2008
p864
sg5
S'PMC2565754'
p865
sg7
g861
sg9
V18845605.xml
p866
sa(dp867
g3
VSTD-Sackley-2009
p868
sg5
S'PMC2736373'
p869
sg7
g861
sg9
V19723707.xml
p870
sa(dp871
g3
VSTD-Chin-A-Paw-2004
p872
sg5
S'PMC471553'
p873
sg7
g861
sg9
V15233841.xml
p874
sa(dp875
g3
VSTD-Gebbia-1996
p876
sg5
S'PMC2074540'
p877
sg7
VCD004310 v. 8.0 Megestrol acetate for treatment of anorexia-cachexia syndrome.rm5
p878
sg9
V8664133.xml
p879
sa(dp880
g3
VSTD-Nilforoushzadeh-2007
p881
sg5
S'PMC1891315'
p882
sg7
VCD005083 v. 7.0 Honey as a topical treatment for wounds.rm5
p883
sg9
V17466071.xml
p884
sa(dp885
g3
VSTD-Baghel-2009
p886
sg5
S'PMC2845359'
p887
sg7
g883
sg9
V20368852.xml
p888
sa(dp889
g3
VSTD-a01-MRC-LU02
p890
sg5
S'PMC1977284'
p891
sg7
VCD002139 v. 10.0 Chemotherapy for non-small cell lung cancer.rm5
p892
sg9
V3907687.xml
p893
sa(dp894
g3
VSTD-d04-RLW-8351
p895
sg5
S'PMC1971367'
p896
sg7
g892
sg9
V1691921.xml
p897
sa(dp898
g3
VSTD-d06-Southampton
p899
sg5
S'PMC1971367'
p900
sg7
g892
sg9
V1691921.xml
p901
sa(dp902
g3
VSTD-Rosenfeldt-2011
p903
sg5
S'PMC3063826'
p904
sg7
VCD010118 v. 2.0 Preoperative physical therapy for elective cardiac surgery patients.rm5
p905
sg9
V21385466.xml
p906
sa(dp907
g3
VSTD-Kylmala-1997
p908
sg5
S'PMC2228066'
p909
sg7
VCD002068 v. 9.0 Bisphosphonates for the relief of pain secondary to bone metastases.rm5
p910
sg9
V9328156.xml
p911
sa(dp912
g3
VSTD-Morice-2007
p913
sg5
S'PMC2228375'
p914
sg7
VCD006924 v. 4.0 Regular treatment with formoterol and inhaled steroids for chronic asthma serious adverse events.rm5
p915
sg9
V17887990.xml
p916
sa(dp917
g3
VSTD-Solomon-2007a
p918
sg5
S'PMC1824772'
p919
sg7
VCD006094 v. 3.0 Interventions for improving the appropriate use of imaging in people with musculoskeletal conditions.rm5
p920
sg9
V17356969.xml
p921
sa(dp922
g3
VSTD-Lafata-2007
p923
sg5
S'PMC1824751'
p924
sg7
g920
sg9
V17356966.xml
p925
sa(dp926
g3
VSTD-Pavord-2007
p927
sg5
S'PMC2174463'
p928
sg7
VCD003137 v. 10.0 Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chron.rm5
p929
sg9
V17897478.xml
p930
sa(dp931
g3
VSTD-Timmer-2002
p932
sg5
S'PMC115863'
p933
sg7
VMR000005 v. 6.0 Full publication of results initially presented in abstracts.rm5
p934
sg9
V11978183.xml
p935
sa(dp936
g3
VSTD-Chel-2008
p937
sg5
S'PMC2277446'
p938
sg7
VCD007470 v. 4.2 Vitamin D supplementation for prevention of mortality in adults.rm5
p939
sg9
V17874029.xml
p940
sa(dp941
g3
VSTD-Ito-2010
p942
sg5
S'PMC2972638'
p943
sg7
VCD000543 v. 11.18 Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
p944
sg9
V20049950.xml
p945
sa(dp946
g3
VSTD-Kruis-2009
p947
sg5
S'PMC3269751'
p948
sg7
g944
sg9
V18832520.xml
p949
sa(dp950
g3
VSTD-Cao-2009
p951
sg5
S'PMC2726958'
p952
sg7
VCD006536 v. 5.0 Stem cell treatment for acute myocardial infarction.rm5
p953
sg9
V19508995.xml
p954
sa(dp955
g3
VSTD-Cuervo-2006
p956
sg5
S'PMC1468428'
p957
sg7
VCD000330 v. 12.0 Enemas during labour.rm5
p958
sg9
V16545140.xml
p959
sa(dp960
g3
VSTD-Bahwere-2008
p961
sg5
S'PMC2536666'
p962
sg7
VCD010119 v. 2.0 Integration of HIVAIDS services with maternal neonatal and child health nutrition and family pla.rm5
p963
sg9
V18671876.xml
p964
sa(dp965
g3
VSTD-Rijal-2010
p966
sg5
S'PMC2856397'
p967
sg7
VCD008602 v. 3.2 Interventions for congenital talipes equinovarus (clubfoot).rm5
p968
sg9
V20419009.xml
p969
sa(dp970
g3
VSTD-Kotwal-1998
p971
sg5
S'PMC2362603'
p972
sg7
VCD005315 v. 3.3 Sensory environment on health-related outcomes of hospital patients.rm5
p973
sg9
V18493472.xml
p974
sa(dp975
g3
VSTD-Choung-2008
p976
sg5
S'PMC2671765'
p977
sg7
VCD009163 v. 2.5 Antibiotics for otitis media with effusion in children.rm5
p978
sg9
V19434268.xml
p979
sa(dp980
g3
VSTD-Huh-2009
p981
sg5
S'PMC2688140'
p982
sg7
VCD009098 v. 3.0 High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult pat.rm5
p983
sg9
V19239703.xml
p984
sa(dp985
g3
VSTD-Bollen-2005
p986
sg5
S'PMC1269459'
p987
sg7
VCD004085 v. 5.2 High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and ac.rm5
p988
sg9
V16137357.xml
p989
sa(dp990
g3
VSTD-Dyhr-2003
p991
sg5
S'PMC154111'
p992
sg7
VCD006667 v. 5.0 Recruitment manoeuvres for adults with acute lung injury receiving mechanical ventilation.rm5
p993
sg9
V12617741.xml
p994
sa(dp995
g3
VSTD-Makvandi-2011
p996
sg5
S'PMC3081214'
p997
sg7
VCD009223 v. 3.0 Non-opioid drugs for pain management in labour.rm5
p998
sg9
V21495198.xml
p999
sa(dp1000
g3
VSTD-Vichinsky-2007
p1001
sg5
S'PMC1974786'
p1002
sg7
VCD007477 v. 5.0 Deferasirox for managing transfusional iron overload in people with sickle cell disease.rm5
p1003
sg9
V17233848.xml
p1004
sa(dp1005
g3
VSTD-Bafna-2011
p1006
sg5
S'PMC3146157'
p1007
sg7
VCD004087 v. 4.8 Pharmacological agents for preventing morbidity associated with the haemodynamic response to trachea.rm5
p1008
sg9
V21804705.xml
p1009
sa(dp1010
g3
VSTD-Montazeri-2011
p1011
sg5
S'PMC3252769'
p1012
sg7
g1008
sg9
V22247722.xml
p1013
sa(dp1014
g3
VSTD-Fujisaka-2011
p1015
sg5
S'PMC3241560'
p1016
sg7
VCD003407 v. 13.2 Erythropoietin or darbepoetin for patients with cancer.rm5
p1017
sg9
V21959870.xml
p1018
sa(dp1019
g3
VSTD-Thatcher-1999b
p1020
sg5
S'PMC2362337'
p1021
sg7
g1017
sg9
V10408844.xml
p1022
sa(dp1023
g3
VSTD-Thatcher-1999a
p1024
sg5
S'PMC2362337'
p1025
sg7
g1017
sg9
V10408844.xml
p1026
sa(dp1027
g3
VSTD-Boogaerts-2003
p1028
sg5
S'PMC2376376'
p1029
sg7
g1017
sg9
V12671693.xml
p1030
sa(dp1031
g3
VSTD-Smith-2003b
p1032
sg5
S'PMC2741110'
p1033
sg7
g1017
sg9
V12799626.xml
p1034
sa(dp1035
g3
VSTD-Smith-2003c
p1036
sg5
S'PMC2741110'
p1037
sg7
g1017
sg9
V12799626.xml
p1038
sa(dp1039
g3
VSTD-Smith-2003a
p1040
sg5
S'PMC2741110'
p1041
sg7
g1017
sg9
V12799626.xml
p1042
sa(dp1043
g3
VSTD-Wilkinson-2006
p1044
sg5
S'PMC2361228'
p1045
sg7
g1017
sg9
V16570051.xml
p1046
sa(dp1047
g3
VSTD-Pronzato-2010
p1048
sg5
S'PMC3228044'
p1049
sg7
g1017
sg9
V20798194.xml
p1050
sa(dp1051
g3
VSTD-Sweeney-1998
p1052
sg5
S'PMC2150364'
p1053
sg7
g1017
sg9
V9667681.xml
p1054
sa(dp1055
g3
VSTD-Thatcher-1999
p1056
sg5
S'PMC2362337'
p1057
sg7
g1017
sg9
V10408844.xml
p1058
sa(dp1059
g3
VSTD-Smith-2003
p1060
sg5
S'PMC2741110'
p1061
sg7
g1017
sg9
V12799626.xml
p1062
sa(dp1063
g3
VSTD-Galloway-2005
p1064
sg5
S'PMC1087493'
p1065
sg7
VCD006140 v. 5.0 Sustained-Release Naltrexone For Opioid Dependence.rm5
p1066
sg9
V15804355.xml
p1067
sa(dp1068
g3
VSTD-Keystone-2009
p1069
sg5
S'PMC2674549'
p1070
sg7
VCD008341 v. 2.0 Golimumab for rheumatoid arthritis.rm5
p1071
sg9
V19066176.xml
p1072
sa(dp1073
g3
VSTD-Jun-2006
p1074
sg5
S'PMC2722000'
p1075
sg7
VCD002907 v. 8.2 Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.rm5
p1076
sg9
V17043424.xml
p1077
sa(dp1078
g3
VSTD-Mendoza-2009
p1079
sg5
S'PMC2680829'
p1080
sg7
VCD005575 v. 6.2 Organisational travel plans for improving health.rm5
p1081
sg9
V19413910.xml
p1082
sa(dp1083
g3
VSTD-Gombocz-2007
p1084
sg5
S'PMC2206488'
p1085
sg7
VCD001319 v. 13.0 Colloid solutions for fluid resuscitation.rm5
p1086
sg9
V17697359.xml
p1087
sa(dp1088
g3
VSTD-Akech-2006
p1089
sg5
S'PMC1569382'
p1090
sg7
g1086
sg9
V16998584.xml
p1091
sa(dp1092
g3
VSTD-Bent-2011
p1093
sg5
S'PMC3076562'
p1094
sg7
VCD007992 v. 3.0 Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).rm5
p1095
sg9
V20683766.xml
p1096
sa(dp1097
g3
VSTD-Hellum-2011
p1098
sg5
S'PMC3100911'
p1099
sg7
VCD008326 v. 5.0 Total disc replacement for chronic back pain in the presence of disc degeneration.rm5
p1100
sg9
V21596740.xml
p1101
sa(dp1102
g3
VSTD-Ito-2010
p1103
sg5
S'PMC2972641'
p1104
sg7
VCD000544 v. 11.0 Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
p1105
sg9
V20049949.xml
p1106
sa(dp1107
g3
VSTD-Kane-2008a
p1108
sg5
S'PMC2770408'
p1109
sg7
g1105
sg9
V19920971.xml
p1110
sa(dp1111
g3
VSTD-Kamm-2008
p1112
sg5
S'PMC2564831'
p1113
sg7
g1105
sg9
V18272546.xml
p1114
sa(dp1115
g3
VSTD-Green-2010
p1116
sg5
S'PMC2890859'
p1117
sg7
VCD009774 v. 2.0 Parent-mediated early intervention for young children with autism spectrum disorders (ASD).rm5
p1118
sg9
V20494434.xml
p1119
sa(dp1120
g3
VSTD-Kasari-2010
p1121
sg5
S'PMC2922697'
p1122
sg7
g1118
sg9
V20145986.xml
p1123
sa(dp1124
g3
VSTD-Sesay-2011
p1125
sg5
S'PMC3024263'
p1126
sg7
VCD003756 v. 6.2 Intermittent preventive treatment for malaria in children living in areas with seasonal transmission.rm5
p1127
sg9
V21214940.xml
p1128
sa(dp1129
g3
VSTD-Konate-2011
p1130
sg5
S'PMC3032552'
p1131
sg7
g1127
sg9
V21304925.xml
p1132
sa(dp1133
g3
VSTD-Kweku-2008
p1134
sg5
S'PMC2602973'
p1135
sg7
g1127
sg9
V19098989.xml
p1136
sa(dp1137
g3
VSTD-Dicko-2011
p1138
sg5
S'PMC3032550'
p1139
sg7
g1127
sg9
V21304923.xml
p1140
sa(dp1141
g3
VSTD-Dicko-2008
p1142
sg5
S'PMC2500037'
p1143
sg7
g1127
sg9
V18611271.xml
p1144
sa(dp1145
g3
VSTD-Sandrini-2007
p1146
sg5
S'PMC1974802'
p1147
sg7
VCD008615 v. 3.2 Sumatriptan (oral route of administration) for acute migraine attacks in adults.rm5
p1148
sg9
V17627707.xml
p1149
sa(dp1150
g3
VSTD-Tfelt_x002d_Hansen-2006
p1151
sg5
S'PMC3452229'
p1152
sg7
g1148
sg9
V17164991.xml
p1153
sa(dp1154
g3
VSTD-Szewczyk-2010
p1155
sg5
S'PMC3298351'
p1156
sg7
VCD000265 v. 15.0 Compression for venous leg ulcers.rm5
p1157
sg9
V22419941.xml
p1158
sa(dp1159
g3
VSTD-El_x002d_Bayoumi-2011
p1160
sg5
S'PMC3387601'
p1161
sg7
VCD002063 v. 10.0 Intravenous immunoglobulin for Guillain-Barr syndrome.rm5
p1162
sg9
V21745374.xml
p1163
sa(dp1164
g3
VSTD-Carlbring-2010
p1165
sg5
S'PMC2882846'
p1166
sg7
VCD008937 v. 2.4 Psychological therapies for pathological and problem gambling.rm5
p1167
sg9
V19967577.xml
p1168
sa(dp1169
g3
VSTD-Endres-2007
p1170
sg5
S'PMC3476149'
p1171
sg7
VCD007587 v. 3.0 Acupuncture for tension-type headache.rm5
p1172
sg9
V17955168.xml
p1173
sa(dp1174
g3
VSTD-Watts-1994
p1175
sg5
S'PMC2366143'
p1176
sg7
VCD000246 v. 8.0 Prophylactic antibiotics for inhibiting preterm labour with intact membranes.rm5
p1177
sg9
V18472878.xml
p1178
sa(dp1179
g3
VSTD-Hibbard-1998
p1180
sg5
S'PMC1784771'
p1181
sg7
VCD001233 v. 8.0 Mechanical methods for induction of labour.rm5
p1182
sg9
V9678143.xml
p1183
sa(dp1184
g3
VSTD-Webster-2010a
p1185
sg5
S'PMC2958861'
p1186
sg7
VCD007393 v. 4.0 Topical capsaicin (high concentration) for chronic neuropathic pain in adults.rm5
p1187
sg9
V20937130.xml
p1188
sa(dp1189
g3
VSTD-Colin-2007a
p1190
sg5
S'PMC2704535'
p1191
sg7
VCD002898 v. 10.0 Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratiti.rm5
p1192
sg9
V19668521.xml
p1193
sa(dp1194
g3
VSTD-Colin-2007b
p1195
sg5
S'PMC2704535'
p1196
sg7
g1192
sg9
V19668521.xml
p1197
sa(dp1198
g3
VSTD-Albrecht-2004
p1199
sg5
S'PMC2395315'
p1200
sg7
VCD005247 v. 4.0 Chemotherapy for hormone-refractory prostate cancer.rm5
p1201
sg9
V14710214.xml
p1202
sa(dp1203
g3
VSTD-Francini-1993
p1204
sg5
S'PMC1968505'
p1205
sg7
g1201
sg9
V8512828.xml
p1206
sa(dp1207
g3
VSTD-Fan-2009
p1208
sg5
S'PMC2781155'
p1209
sg7
VCD006023 v. 6.0 Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.rm5
p1210
sg9
V19666658.xml
p1211
sa(dp1212
g3
VSTD-Tzanakis-2008
p1213
sg5
S'PMC2268719'
p1214
sg7
g1210
sg9
V18193489.xml
p1215
sa(dp1216
g3
VSTD-Dietz-2010
p1217
sg5
S'PMC2808513'
p1218
sg7
VCD004014 v. 8.0 Surgical management of pelvic organ prolapse in women.rm5
p1219
sg9
V19834635.xml
p1220
sa(dp1221
g3
VSTD-Carey-2009
p1222
sg5
S'PMC2774153'
p1223
sg7
g1219
sg9
V19583714.xml
p1224
sa(dp1225
g3
VSTD-Feary-2009a
p1226
sg5
S'PMC2728895'
p1227
sg7
VCD009238 v. 3.0 Helminth therapy (worms) for allergic rhinitis.rm5
p1228
sg9
V19400893.xml
p1229
sa(dp1230
g3
VSTD-Perria-2007
p1231
sg5
S'PMC1904445'
p1232
sg7
VCD004398 v. 10.0 Printed educational materials effects on professional practice and healthcare outcomes.rm5
p1233
sg9
V17547760.xml
p1234
sa(dp1235
g3
VSTD-Carey-2005
p1236
sg5
S'PMC547907'
p1237
sg7
VCD008141 v. 2.3 Second-generation antipsychotics for obsessive compulsive disorder.rm5
p1238
sg9
V15667657.xml
p1239
sa(dp1240
g3
VSTD-Norrkoping
p1241
sg5
S'PMC3069219'
p1242
sg7
VCD004720 v. 8.0 Screening for prostate cancer.rm5
p1243
sg9
V21454449.xml
p1244
sa(dp1245
g3
VSTD-Rosen-1998
p1246
sg5
S'PMC3015270'
p1247
sg7
VCD003348 v. 9.0 Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain.rm5
p1248
sg9
V9876706.xml
p1249
sa(dp1250
g3
VSTD-Willems-2007a
p1251
sg5
S'PMC2000864'
p1252
sg7
VCD007717 v. 3.0 Telehealthcare for asthma.rm5
p1253
sg9
V17662113.xml
p1254
sa(dp1255
g3
VSTD-Sadighi-2006
p1256
sg5
S'PMC1693922'
p1257
sg7
VCD004064 v. 10.0 Chemotherapy for advanced gastric cancer.rm5
p1258
sg9
V17147808.xml
p1259
sa(dp1260
g3
VSTD-Moehler-2005
p1261
sg5
S'PMC2361806'
p1262
sg7
g1258
sg9
V15942629.xml
p1263
sa(dp1264
g3
VSTD-Pyrh_x00f6_nen-1995
p1265
sg5
S'PMC2033628'
p1266
sg7
g1258
sg9
V7533517.xml
p1267
sa(dp1268
g3
VSTD-de-Benedictis-1994b
p1269
sg5
S'PMC2365597'
p1270
sg7
VCD002731 v. 6.0 Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction.rm5
p1271
sg9
V18475602.xml
p1272
sa(dp1273
g3
VSTD-Bachewar-2009
p1274
sg5
S'PMC2825021'
p1275
sg7
VCD000320 v. 14.0 Interventions for treating scabies.rm5
p1276
sg9
V20177574.xml
p1277
sa(dp1278
g3
VSTD-Popelut-2010
p1279
sg5
S'PMC2858083'
p1280
sg7
VMR000033 v. 3.0 Industry sponsorship and research outcome.rm5
p1281
sg9
V20422000.xml
p1282
sa(dp1283
g3
VSTD-Bero-2007
p1284
sg5
S'PMC1885451'
p1285
sg7
g1281
sg9
V17550302.xml
p1286
sa(dp1287
g3
VSTD-Clifford-2002
p1288
sg5
S'PMC126226'
p1289
sg7
g1281
sg9
V12213183.xml
p1290
sa(dp1291
g3
VSTD-Jefferson-2009
p1292
sg5
S'PMC2643439'
p1293
sg7
g1281
sg9
V19213766.xml
p1294
sa(dp1295
g3
VSTD-Rasmussen-2009
p1296
sg5
S'PMC2811705'
p1297
sg7
g1281
sg9
V20015404.xml
p1298
sa(dp1299
g3
VSTD-Rattinger-2009
p1300
sg5
S'PMC2688752'
p1301
sg7
g1281
sg9
V19503811.xml
p1302
sa(dp1303
g3
VSTD-Ekeberg-2009
p1304
sg5
S'PMC2769057'
p1305
sg7
VCD009147 v. 2.0 Image-guided versus blind glucocorticoid injection for shoulder pain.rm5
p1306
sg9
V19168537.xml
p1307
sa(dp1308
g3
VSTD-Xiao-2008
p1309
sg5
S'PMC2447617'
p1310
sg7
VCD008409 v. 3.3 Progesterone for acute traumatic brain injury.rm5
p1311
sg9
V18447940.xml
p1312
sa(dp1313
g3
VSTD-van-de-Vusse-2004
p1314
sg5
S'PMC523854'
p1315
sg7
VCD007938 v. 4.0 Gabapentin for chronic neuropathic pain and fibromyalgia in adults.rm5
p1316
sg9
V15453912.xml
p1317
sa(dp1318
g3
VSTD-Rashidi-2011
p1319
sg5
S'PMC3446117'
p1320
sg7
VCD009415 v. 2.0 Zinc supplements for treating thalassaemia and sickle cell disease.rm5
p1321
sg9
V23056757.xml
p1322
sa(dp1323
g3
VSTD-De-Benedictis-1994b
p1324
sg5
S'PMC2365597'
p1325
sg7
VCD001183 v. 10.0 Nedocromil sodium for preventing exercise-induced bronchoconstriction.rm5
p1326
sg9
V18475602.xml
p1327
sa(dp1328
g3
VSTD-Baradaran-2006
p1329
sg5
S'PMC1489930'
p1330
sg7
VCD006424 v. 2.0 Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups.rm5
p1331
sg9
V16709243.xml
p1332
sa(dp1333
g3
VSTD-Gray-1991
p1334
sg5
S'PMC1972556'
p1335
sg7
VCD005390 v. 4.0 Adjuvant Therapy for completely resected Stage II Colon Cancer.rm5
p1336
sg9
V2069842.xml
p1337
sa(dp1338
g3
VSTD-Taal-2001
p1339
sg5
S'PMC2363941'
p1340
sg7
g1336
sg9
V11720425.xml
p1341
sa(dp1342
g3
VSTD-Mikamo-_x0028_1_x0029_-1995
p1343
sg5
S'PMC2364408'
p1344
sg7
VCD002845 v. 6.0 Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal.rm5
p1345
sg9
V18475414.xml
p1346
sa(dp1347
g3
VSTD-Seidman-2005
p1348
sg5
S'PMC1784583'
p1349
sg7
g1345
sg9
V16338779.xml
p1350
sa(dp1351
g3
VSTD-Mikamo-_x0028_2_x0029_-1995
p1352
sg5
S'PMC2364408'
p1353
sg7
g1345
sg9
V18475414.xml
p1354
sa(dp1355
g3
VSTD-Menon-2007
p1356
sg5
S'PMC2636008'
p1357
sg7
VCD001430 v. 10.0 Corticosteroids for treating optic neuritis.rm5
p1358
sg9
V17699944.xml
p1359
sa(dp1360
g3
VSTD-Luabeya-2007
p1361
sg5
S'PMC1891438'
p1362
sg7
VCD008563 v. 2.0 Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.rm5
p1363
sg9
V17593956.xml
p1364
sa(dp1365
g3
VSTD-O_x0027_Connor-2009
p1366
sg5
S'PMC2699722'
p1367
sg7
VCD000259 v. 11.2 Audit and feedback effects on professional practice and healthcare outcomes.rm5
p1368
sg9
V19366977.xml
p1369
sa(dp1370
g3
VSTD-Schneider-2008
p1371
sg5
S'PMC2440309'
p1372
sg7
g1368
sg9
V18093108.xml
p1373
sa(dp1374
g3
VSTD-Foster-2007
p1375
sg5
S'PMC1868738'
p1376
sg7
g1368
sg9
V17456241.xml
p1377
sa(dp1378
g3
VSTD-Hemminki-2008
p1379
sg5
S'PMC2442595'
p1380
sg7
VCD005528 v. 4.0 Non-clinical interventions for reducing unnecessary caesarean section.rm5
p1381
sg9
V18547413.xml
p1382
sa(dp1383
g3
VSTD-Kneyber-2009
p1384
sg5
S'PMC2717432'
p1385
sg7
VCD006915 v. 5.0 Heliox inhalation therapy for bronchiolitis in infants.rm5
p1386
sg9
V19450268.xml
p1387
sa(dp1388
g3
VSTD-Razavi-2002
p1389
sg5
S'PMC2364281'
p1390
sg7
VCD003751 v. 5.0 Communication skills training for healthcare professionals working with people who have cancer.rm5
p1391
sg9
V12085247.xml
p1392
sa(dp1393
g3
VSTD-Lienard-2010
p1394
sg5
S'PMC2906741'
p1395
sg7
g1391
sg9
V20628395.xml
p1396
sa(dp1397
g3
VSTD-Elsinga-2006
p1398
sg5
S'PMC1552064'
p1399
sg7
VCD007536 v. 2.0 Routine pre-pregnancy health promotion for improving pregnancy outcomes.rm5
p1400
sg9
V16824233.xml
p1401
sa(dp1402
g3
VSTD-Lumley-2006
p1403
sg5
S'PMC1712341'
p1404
sg7
g1400
sg9
V17156466.xml
p1405
sa(dp1406
g3
VSTD-Reis-Neto-2002
p1407
sg5
S'PMC3043413'
p1408
sg7
VCD005200 v. 3.0 Laparoscopic versus open total mesorectal excision for rectal cancer.rm5
p1409
sg9
V12113422.xml
p1410
sa(dp1411
g3
VSTD-BRAIN-2009
p1412
sg5
S'PMC2794266'
p1413
sg7
VCD006686 v. 7.0 Bradykinin beta-2 receptor antagonists for acute traumatic brain injury.rm5
p1414
sg9
V19958521.xml
p1415
sa(dp1416
g3
VSTD-Riccardi-1994
p1417
sg5
S'PMC2033710'
p1418
sg7
VCD004023 v. 8.0 Early versus deferred treatment for early stage multiple myeloma.rm5
p1419
sg9
V7981078.xml
p1420
sa(dp1421
g3
VSTD-Riccardi-2000
p1422
sg5
S'PMC2374495'
p1423
sg7
g1419
sg9
V10755397.xml
p1424
sa(dp1425
g3
VSTD-Fraser-S-1993
p1426
sg5
S'PMC1968186'
p1427
sg7
VCD003372 v. 8.0 Single agent versus combination chemotherapy for metastatic breast cancer.rm5
p1428
sg9
V8431375.xml
p1429
sa(dp1430
g3
VSTD-Rubens-RD-1975
p1431
sg5
S'PMC2025018'
p1432
sg7
g1428
sg9
V766800.xml
p1433
sa(dp1434
g3
VSTD-LEAD_x002d_3-2006
p1435
sg5
S'PMC3084519'
p1436
sg7
VCD009008 v. 2.6 Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.rm5
p1437
sg9
V21205128.xml
p1438
sa(dp1439
g3
VSTD-Calverley-2008
p1440
sg5
S'PMC2644301'
p1441
sg7
VCD002991 v. 7.0 Inhaled corticosteroids for stable chronic obstructive pulmonary disease.rm5
p1442
sg9
V19014549.xml
p1443
sa(dp1444
g3
VSTD-Schermer-2009
p1445
sg5
S'PMC2793071'
p1446
sg7
g1442
sg9
V20037682.xml
p1447
sa(dp1448
g3
VSTD-Halm-2009
p1449
sg5
S'PMC2690844'
p1450
sg7
VCD005199 v. 7.0 Transverse verses midline incisions for abdominal surgery.rm5
p1451
sg9
V19259615.xml
p1452
sa(dp1453
g3
VSTD-Matsegui-2008
p1454
sg5
S'PMC2409363'
p1455
sg7
VCD002151 v. 7.0 Antipyretic measures for treating fever in malaria.rm5
p1456
sg9
V18503714.xml
p1457
sa(dp1458
g3
VSTD-Kofoed-2011
p1459
sg5
S'PMC3123603'
p1460
sg7
g1456
sg9
V21631932.xml
p1461
sa(dp1462
g3
VSTD-Meyer-2008
p1463
sg5
S'PMC2253708'
p1464
sg7
VCD001118 v. 10.0 Self-help interventions for smoking cessation.rm5
p1465
sg9
V17995993.xml
p1466
sa(dp1467
g3
VSTD-Donskov_x0028_ii_x0029_-2005
p1468
sg5
S'PMC2361635'
p1469
sg7
VCD001425 v. 6.0 Immunotherapy for advanced renal cell cancer.rm5
p1470
sg9
V16136045.xml
p1471
sa(dp1472
g3
VSTD-Jayson-1998
p1473
sg5
S'PMC2063040'
p1474
sg7
g1470
sg9
V9703284.xml
p1475
sa(dp1476
g3
VSTD-DeMulder-1995
p1477
sg5
S'PMC2033601'
p1478
sg7
g1470
sg9
V7841054.xml
p1479
sa(dp1480
g3
VSTD-Donskov_x0028_i_x0029_-2005
p1481
sg5
S'PMC2361635'
p1482
sg7
g1470
sg9
V16136045.xml
p1483
sa(dp1484
g3
VSTD-Henriksson-1998
p1485
sg5
S'PMC2150170'
p1486
sg7
g1470
sg9
V9579838.xml
p1487
sa(dp1488
g3
VSTD-Atzpodien-2001
p1489
sg5
S'PMC2375150'
p1490
sg7
g1470
sg9
V11710825.xml
p1491
sa(dp1492
g3
VSTD-Whittaker-2011
p1493
sg5
S'PMC3221331'
p1494
sg7
VCD006611 v. 4.4 Mobile phone-based interventions for smoking cessation.rm5
p1495
sg9
V21371991.xml
p1496
sa(dp1497
g3
VSTD-Free-2011
p1498
sg5
S'PMC3143315'
p1499
sg7
g1495
sg9
V21722952.xml
p1500
sa(dp1501
g3
VSTD-COMPASS
p1502
sg5
S'PMC1920547'
p1503
sg7
VCD004106 v. 9.0 Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for c.rm5
p1504
sg9
V17362472.xml
p1505
sa(dp1506
g3
VSTD-McMurdo-2009
p1507
sg5
S'PMC2639265'
p1508
sg7
VCD001321 v. 17.0 Cranberries for preventing urinary tract infections.rm5
p1509
sg9
V19042940.xml
p1510
sa(dp1511
g3
VSTD-Young-2008
p1512
sg5
S'PMC2268921'
p1513
sg7
VCD002850 v. 9.0 Telephone counselling for smoking cessation.rm5
p1514
sg9
V18304363.xml
p1515
sa(dp1516
g3
VSTD-Fretheim-2007
p1517
sg5
S'PMC1904466'
p1518
sg7
VCD008654 v. 1.0 Pharmaceutical policies effects of restrictions on reimbursement.rm5
p1519
sg9
V17622192.xml
p1520
sa(dp1521
g3
VSTD-Lee-2007
p1522
sg5
S'PMC2206510'
p1523
sg7
VCD001000 v. 12.0 Corticosteroids for the prevention and treatment of post-extubation stridor in neonates children an.rm5
p1524
sg9
V17705879.xml
p1525
sa(dp1526
g3
VSTD-Fagerstrom-2010
p1527
sg5
S'PMC2997603'
p1528
sg7
VCD004306 v. 9.0 Interventions for smokeless tobacco use cessation.rm5
p1529
sg9
V21134997.xml
p1530
sa(dp1531
g3
VSTD-White-2007
p1532
sg5
S'PMC1831486'
p1533
sg7
VCD000009 v. 11.0 Acupuncture and related interventions for smoking cessation.rm5
p1534
sg9
V17359519.xml
p1535
sa(dp1536
g3
VSTD-Luabeya-2007
p1537
sg5
S'PMC1891438'
p1538
sg7
VCD005978 v. 9.0 Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.rm5
p1539
sg9
V17593956.xml
p1540
sa(dp1541
g3
VSTD-Mohide-1996
p1542
sg5
S'PMC2074537'
p1543
sg7
VCD008273 v. 3.0 Information interventions for orienting patients and their carers to cancer care facilities.rm5
p1544
sg9
V8664135.xml
p1545
sa(dp1546
g3
VSTD-Hemsell-1993
p1547
sg5
S'PMC2364680'
p1548
sg7
VCD005987 v. 5.0 Scalpel versus electrosurgery for abdominal incisions.rm5
p1549
sg9
V18476202.xml
p1550
sa(dp1551
g3
VSTD-Leykin-2008
p1552
sg5
S'PMC2615351'
p1553
sg7
VCD007126 v. 5.0 Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain.rm5
p1554
sg9
V18581586.xml
p1555
sa(dp1556
g3
VSTD-Totapally-2002
p1557
sg5
S'PMC111183'
p1558
sg7
VCD001266 v. 7.0 Bronchodilators for bronchiolitis.rm5
p1559
sg9
V11983043.xml
p1560
sa(dp1561
g3
VSTD-Dent-2011
p1562
sg5
S'PMC3113983'
p1563
sg7
VMR000024 v. 5.0 New treatments compared to established treatments in randomized trials.rm5
p1564
sg9
V21542934.xml
p1565
sa(dp1566
g3
VSTD-Smith-2003
p1567
sg5
S'PMC2741110'
p1568
sg7
VCD006704 v. 7.2 Drug therapy for the management of cancer-related fatigue.rm5
p1569
sg9
V12799626.xml
p1570
sa(dp1571
g3
VSTD-Boogaerts-2003
p1572
sg5
S'PMC2376376'
p1573
sg7
g1569
sg9
V12671693.xml
p1574
sa(dp1575
g3
VSTD-Thatcher-1999
p1576
sg5
S'PMC2362337'
p1577
sg7
g1569
sg9
V10408844.xml
p1578
sa(dp1579
g3
VSTD-Wilkinson-2006
p1580
sg5
S'PMC2361228'
p1581
sg7
g1569
sg9
V16570051.xml
p1582
sa(dp1583
g3
VSTD-Madlung_x002d_Kratzer-2009
p1584
sg5
S'PMC2773536'
p1585
sg7
VCD003409 v. 19.0 Methadone at tapered doses for the management of opioid withdrawal.rm5
p1586
sg9
V19686525.xml
p1587
sa(dp1588
g3
VSTD-Carling-2009
p1589
sg5
S'PMC2724738'
p1590
sg7
VCD006776 v. 6.0 Using alternative statistical formats for presenting risks and risk reductions.rm5
p1591
sg9
V19707575.xml
p1592
sa(dp1593
g3
VSTD-Carling-2008
p1594
sg5
S'PMC2585274'
p1595
sg7
g1591
sg9
V19030110.xml
p1596
sa(dp1597
g3
VSTD-Sharafi-2010
p1598
sg5
S'PMC3446002'
p1599
sg7
VCD009017 v. 2.0 Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia.rm5
p1600
sg9
V23056681.xml
p1601
sa(dp1602
g3
VSTD-Lorente-2006
p1603
sg5
S'PMC1750976'
p1604
sg7
VCD004711 v. 6.0 Heated humidification versus heat and moisture exchangers for ventilated adults and children.rm5
p1605
sg9
V16884530.xml
p1606
sa(dp1607
g3
VSTD-UK-ANZ-Trial-2011
p1608
sg5
S'PMC3018565'
p1609
sg7
VCD007847 v. 2.0 Postoperative tamoxifen for ductal carcinoma in situ.rm5
p1610
sg9
V21145284.xml
p1611
sa(dp1612
g3
VSTD-Vodermaier-2009
p1613
sg5
S'PMC2653746'
p1614
sg7
VCD001431 v. 9.0 Decision aids for people facing health treatment or screening decisions.rm5
p1615
sg9
V19209172.xml
p1616
sa(dp1617
g3
VSTD-Sheridan-2006
p1618
sg5
S'PMC1626460'
p1619
sg7
g1615
sg9
V17005051.xml
p1620
sa(dp1621
g3
VSTD-Thomson-2007
p1622
sg5
S'PMC1781432'
p1623
sg7
g1615
sg9
V17214891.xml
p1624
sa(dp1625
g3
VSTD-Hutchison-2007
p1626
sg5
S'PMC2360384'
p1627
sg7
VMR000013 v. 10.0 Strategies to improve recruitment to randomised controlled trials.rm5
p1628
sg9
V17848908.xml
p1629
sa(dp1630
g3
VSTD-RESOLVE
p1631
sg5
S'PMC2963502'
p1632
sg7
VCD007419 v. 4.0 Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular .rm5
p1633
sg9
V20980427.xml
p1634
sa(dp1635
g3
VSTD-Dixon-1992
p1636
sg5
S'PMC1977824'
p1637
sg7
VCD002747 v. 11.0 Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.rm5
p1638
sg9
V1503915.xml
p1639
sa(dp1640
g3
VSTD-Brookfield-2009
p1641
sg5
S'PMC2612742'
p1642
sg7
VCD007945 v. 3.0 Centralisation of services for gynaecological cancer.rm5
p1643
sg9
V19125205.xml
p1644
sa(dp1645
g3
VSTD-Stockton-2000
p1646
sg5
S'PMC2363169'
p1647
sg7
g1643
sg9
V10638991.xml
p1648
sa(dp1649
g3
VSTD-Carling-2010
p1650
sg5
S'PMC2830888'
p1651
sg7
VCD006777 v. 3.0 Framing of health information messages.rm5
p1652
sg9
V20209127.xml
p1653
sa(dp1654
g3
VSTD-MacArthur-2009
p1655
sg5
S'PMC2636685'
p1656
sg7
VCD006425 v. 5.3 Antenatal breastfeeding education for increasing breastfeeding duration.rm5
p1657
sg9
V19181730.xml
p1658
sa(dp1659
g3
VSTD-Arjyal-2011
p1660
sg5
S'PMC3108101'
p1661
sg7
VCD004530 v. 8.0 Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).rm5
p1662
sg9
V21531174.xml
p1663
sa(dp1664
g3
VSTD-Pandit-2007-NPL
p1665
sg5
S'PMC1891439'
p1666
sg7
g1662
sg9
V17593957.xml
p1667
sa(dp1668
g3
VSTD-Dolecek-2008-VNM
p1669
sg5
S'PMC2374894'
p1670
sg7
g1662
sg9
V18493312.xml
p1671
sa(dp1672
g3
VSTD-Thunander-2010
p1673
sg5
S'PMC3022338'
p1674
sg7
VCD006165 v. 5.0 Interventions for latent autoimmune diabetes (LADA) in adults.rm5
p1675
sg9
V21088056.xml
p1676
sa(dp1677
g3
VSTD-Hatch-2011
p1678
sg5
S'PMC3090298'
p1679
sg7
VCD005135 v. 5.2 Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.rm5
p1680
sg9
V21573091.xml
p1681
sa(dp1682
g3
VSTD-Eddleston-2009
p1683
sg5
S'PMC2696321'
p1684
sg7
VCD005085 v. 4.0 Oximes for acute organophosphate pesticide poisoning.rm5
p1685
sg9
V19564902.xml
p1686
sa(dp1687
g3
VSTD-Ried-2009
p1688
sg5
S'PMC2712451'
p1689
sg7
VCD008893 v. 3.1 Effect of cocoa on blood pressure.rm5
p1690
sg9
V19583878.xml
p1691
sa(dp1692
g3
VSTD-Fraga-2005
p1693
sg5
S'PMC2270716'
p1694
sg7
g1690
sg9
V15712594.xml
p1695
sa(dp1696
g3
VSTD-DeWalt-2006
p1697
sg5
S'PMC1475568'
p1698
sg7
VCD007228 v. 4.0 Structured telephone support or telemonitoring programmes for patients with chronic heart failure.rm5
p1699
sg9
V16533388.xml
p1700
sa(dp1701
g3
VSTD-Martins-2009
p1702
sg5
S'PMC2767482'
p1703
sg7
VCD007952 v. 2.6 Material incentives and enablers in the management of tuberculosis.rm5
p1704
sg9
V19858174.xml
p1705
sa(dp1706
g3
VSTD-Cockayne-2011
p1707
sg5
S'PMC3109952'
p1708
sg7
VCD001781 v. 10.0 Topical treatments for cutaneous warts.rm5
p1709
sg9
V21652750.xml
p1710
sa(dp1711
g3
VSTD-Fuchs-2004
p1712
sg5
S'PMC2703213'
p1713
sg7
g1709
sg9
V19675691.xml
p1714
sa(dp1715
g3
VSTD-TXT-Group
p1716
sg5
S'PMC2408916'
p1717
sg7
VCD003366 v. 9.0 Taxane containing regimens for metastatic breast cancer.rm5
p1718
sg9
V12439707.xml
p1719
sa(dp1720
g3
VSTD-Talbot
p1721
sg5
S'PMC2375384'
p1722
sg7
g1718
sg9
V11986765.xml
p1723
sa(dp1724
g3
VSTD-Lindell-2008
p1725
sg5
S'PMC2649916'
p1726
sg7
VCD007407 v. 4.2 Psychological therapies for the management of chronic pain (excluding headache) in adults.rm5
p1727
sg9
V19116007.xml
p1728
sa(dp1729
g3
VSTD-Kotwal-1998
p1730
sg5
S'PMC2362603'
p1731
sg7
VCD004843 v. 10.2 Music for pain relief.rm5
p1732
sg9
V18493472.xml
p1733
sa(dp1734
g3
VSTD-Rennard-2009
p1735
sg5
S'PMC3580134'
p1736
sg7
VCD006829 v. 8.0 Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonis.rm5
p1737
sg9
V19368417.xml
p1738
sa(dp1739
g3
VSTD-Aranda-2006
p1740
sg5
S'PMC2360523'
p1741
sg7
VCD004253 v. 10.0 Psychological interventions for women with metastatic breast cancer.rm5
p1742
sg9
V16967054.xml
p1743
sa(dp1744
g3
VSTD-Jones-2008
p1745
sg5
S'PMC2556688'
p1746
sg7
VCD007651 v. 3.0 School-based physical activity programs for promoting physical activity and fitness in children and .rm5
p1747
sg9
V18718012.xml
p1748
sa(dp1749
g3
VSTD-Kriemler-2010
p1750
sg5
S'PMC2827713'
p1751
sg7
g1747
sg9
V20179126.xml
p1752
sa(dp1753
g3
VSTD-Gentile-2009
p1754
sg5
S'PMC2758893'
p1755
sg7
g1747
sg9
V19765270.xml
p1756
sa(dp1757
g3
VSTD-Poikolainen-2008
p1758
sg5
S'PMC2265283'
p1759
sg7
VCD008358 v. 3.0 Magnesium for alcohol withdrawal.rm5
p1760
sg9
V18218147.xml
p1761
sa(dp1762
g3
VSTD-Fretheim-2006
p1763
sg5
S'PMC1472695'
p1764
sg7
VCD005470 v. 5.0 Tailored interventions to overcome identified barriers to change effects on professional practice a.rm5
p1765
sg9
V16737346.xml
p1766
sa(dp1767
g3
VSTD-Cameron-2001
p1768
sg5
S'PMC2363881'
p1769
sg7
VCD008955 v. 2.2 Interferon alpha for the adjuvant treatment of cutaneous melanoma.rm5
p1770
sg9
V11379605.xml
p1771
sa(dp1772
g3
VSTD-Keiser-2005
p1773
sg5
S'PMC548524'
p1774
sg7
VCD008270 v. 2.5 Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.rm5
p1775
sg9
V15647105.xml
p1776
sa(dp1777
g3
VSTD-Veldt-2003
p1778
sg5
S'PMC222984'
p1779
sg7
VCD005527 v. 5.4 Ribavirin monotherapy for chronic hepatitis C.rm5
p1780
sg9
V12948399.xml
p1781
sa(dp1782
g3
VSTD-O_x0027_Sullivan-2009
p1783
sg5
S'PMC2660391'
p1784
sg7
VCD003930 v. 8.0 Restricting oral fluid and food intake during labour.rm5
p1785
sg9
V19318702.xml
p1786
sa(dp1787
g3
VSTD-MAINTAIN-Nephritis-Study
p1788
sg5
S'PMC3002764'
p1789
sg7
VCD002922 v. 9.2 Treatment for lupus nephritis.rm5
p1790
sg9
V20833738.xml
p1791
sa(dp1792
g3
VSTD-Charles-2009
p1793
sg5
S'PMC2680945'
p1794
sg7
VMR000031 v. 2.3 Comparison of protocols and registry entries to published reports for randomised controlled trials.rm5
p1795
sg9
V19435763.xml
p1796
sa(dp1797
g3
VSTD-Neuhaus-2009
p1798
sg5
S'PMC2634726'
p1799
sg7
VCD007464 v. 3.2 Chemotherapy for brain metastases from small cell lung cancer.rm5
p1800
sg9
V19127261.xml
p1801
sa(dp1802
g3
VSTD-MAM-01-GOCSI
p1803
sg5
S'PMC2362097'
p1804
sg7
VCD004562 v. 7.0 LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.rm5
p1805
sg9
V15668708.xml
p1806
sa(dp1807
g3
VSTD-Pakistan-2011
p1808
sg5
S'PMC3041931'
p1809
sg7
VCD000494 v. 11.0 Prostaglandins for preventing postpartum haemorrhage.rm5
p1810
sg9
V21176086.xml
p1811
sa(dp1812
g3
VSTD-Chen-2010
p1813
sg5
S'PMC2924475'
p1814
sg7
VCD008016 v. 3.2 Maintenance treatment with antipsychotic drugs for schizophrenia.rm5
p1815
sg9
V20724402.xml
p1816
sa(dp1817
g3
VSTD-Channabasavanna-1987
p1818
sg5
S'PMC3172444'
p1819
sg7
g1815
sg9
V21927264.xml
p1820
sa(dp1821
g3
VSTD-Pyrhonen-1997
p1822
sg5
S'PMC2223944'
p1823
sg7
VCD008926 v. 2.0 Toremifene versus tamoxifen for advanced breast cancer.rm5
p1824
sg9
V9231932.xml
p1825
sa(dp1826
g3
VSTD-Chirico-2009
p1827
sg5
S'PMC2687544'
p1828
sg7
VCD006602 v. 7.0 Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.rm5
p1829
sg9
V19490659.xml
p1830
sa(dp1831
g3
VSTD-Nuijten-2010
p1832
sg5
S'PMC2816247'
p1833
sg7
g1829
sg9
V19967425.xml
p1834
sa(dp1835
g3
VSTD-Colford-2002
p1836
sg5
S'PMC2730258'
p1837
sg7
VCD004794 v. 3.0 Interventions to improve water quality for preventing diarrhoea.rm5
p1838
sg9
V11749745.xml
p1839
sa(dp1840
g3
VSTD-Namutangula-2007
p1841
sg5
S'PMC2147028'
p1842
sg7
VCD004615 v. 5.2 Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.rm5
p1843
sg9
V17958887.xml
p1844
sa(dp1845
g3
VSTD-Rosenson-2009
p1846
sg5
S'PMC2681027'
p1847
sg7
VCD008226 v. 2.0 Lipid lowering efficacy of atorvastatin.rm5
p1848
sg9
V19265025.xml
p1849
sa(dp1850
g3
VSTD-Park-2010
p1851
sg5
S'PMC2829413'
p1852
sg7
g1848
sg9
V20195400.xml
p1853
sa(dp1854
g3
VSTD-Cho-2011
p1855
sg5
S'PMC3079135'
p1856
sg7
g1848
sg9
V21519514.xml
p1857
sa(dp1858
g3
VSTD-Louie-2011
p1859
sg5
S'PMC3198285'
p1860
sg7
VCD009275 v. 2.0 Different types of dietary advice for women with gestational diabetes mellitus.rm5
p1861
sg9
V21900148.xml
p1862
sa(dp1863
g3
VSTD-Moses-2009
p1864
sg5
S'PMC2681032'
p1865
sg7
g1861
sg9
V19279301.xml
p1866
sa(dp1867
g3
VSTD-Del-Giglio-2008
p1868
sg5
S'PMC2628928'
p1869
sg7
VCD007913 v. 2.0 Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile n.rm5
p1870
sg9
V19014494.xml
p1871
sa(dp1872
g3
VSTD-Bakker-2007
p1873
sg5
S'PMC1885369'
p1874
sg7
VCD006389 v. 3.0 Interventions to facilitate return to work in adults with adjustment disorders.rm5
p1875
sg9
V17549228.xml
p1876
sa(dp1877
g3
VSTD-Oh-2010
p1878
sg5
S'PMC2826100'
p1879
sg7
VCD007566 v. 2.2 Exercise interventions on health-related quality of life for cancer survivors.rm5
p1880
sg9
V19880433.xml
p1881
sa(dp1882
g3
VSTD-Sutherland-2005
p1883
sg5
S'PMC1087200'
p1884
sg7
VCD005564 v. 6.0 Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.rm5
p1885
sg9
V15839740.xml
p1886
sa(dp1887
g3
VSTD-Eslami-2005
p1888
sg5
S'PMC1502073'
p1889
sg7
VCD003611 v. 7.0 Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.rm5
p1890
sg9
V16943938.xml
p1891
sa(dp1892
g3
VSTD-Chavan-2010
p1893
sg5
S'PMC3034455'
p1894
sg7
g1890
sg9
V21358799.xml
p1895
sa(dp1896
g3
VSTD-FACS-2010
p1897
sg5
S'PMC2886041'
p1898
sg7
VCD006870 v. 4.0 Statins for acute coronary syndrome.rm5
p1899
sg9
V20500832.xml
p1900
sa(dp1901
g3
VSTD-Sims-2006
p1902
sg5
S'PMC1698486'
p1903
sg7
VCD002759 v. 7.0 Progressive resistance strength training for improving physical function in older adults.rm5
p1904
sg9
V17134517.xml
p1905
sa(dp1906
g3
VSTD-Kluger-2007
p1907
sg5
S'PMC2206502'
p1908
sg7
VCD007877 v. 2.0 Haemostatic drugs for traumatic brain injury.rm5
p1909
sg9
V17686152.xml
p1910
sa(dp1911
g3
VSTD-Sheikh-2002
p1912
sg5
S'PMC116603'
p1913
sg7
VCD001187 v. 9.0 House dust mite control measures for asthma.rm5
p1914
sg9
V12079502.xml
p1915
sa(dp1916
g3
VSTD-Sokal-2004
p1917
sg5
S'PMC406425'
p1918
sg7
VCD003991 v. 10.0 Vasectomy occlusion techniques for male sterilization.rm5
p1919
sg9
V15056388.xml
p1920
sa(dp1921
g3
VSTD-Lofgren-2010
p1922
sg5
S'PMC2899760'
p1923
sg7
VCD004958 v. 8.0 Single or double-level anterior interbody fusion techniques for cervical degenerative disc disease.rm5
p1924
sg9
V19763634.xml
p1925
sa(dp1926
g3
VSTD-Southampton
p1927
sg5
S'PMC1971367'
p1928
sg7
VCD007309 v. 5.0 Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cance.rm5
p1929
sg9
V1691921.xml
p1930
sa(dp1931
g3
VSTD-RLW-8351
p1932
sg5
S'PMC1971367'
p1933
sg7
g1929
sg9
V1691921.xml
p1934
sa(dp1935
g3
VSTD-Manchester-1
p1936
sg5
S'PMC2374661'
p1937
sg7
g1929
sg9
V10945489.xml
p1938
sa(dp1939
g3
VSTD-Charleston-1996
p1940
sg5
S'PMC2364502'
p1941
sg7
VCD002256 v. 9.0 Treatments for symptomatic urinary tract infections during pregnancy.rm5
p1942
sg9
V18476110.xml
p1943
sa(dp1944
g3
VSTD-Lim-2009
p1945
sg5
S'PMC2687520'
p1946
sg7
VCD008586 v. 2.0 Antiepileptic drugs for treating seizures in adults with brain tumours.rm5
p1947
sg9
V19169651.xml
p1948
sa(dp1949
g3
VSTD-Itoh-2008
p1950
sg5
S'PMC2268695'
p1951
sg7
VCD002823 v. 8.2 Transcutaneous electrostimulation for osteoarthritis of the knee.rm5
p1952
sg9
V18312661.xml
p1953
sa(dp1954
g3
VSTD-Charron_x002d_Prochownik-2008
p1955
sg5
S'PMC2453657'
p1956
sg7
VCD007776 v. 3.0 Preconception care for diabetic women for improving maternal and infant health.rm5
p1957
sg9
V18411239.xml
p1958
sa(dp1959
g3
VSTD-Ringdal-1996
p1960
sg5
S'PMC2365805'
p1961
sg7
VCD002310 v. 11.2 Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.rm5
p1962
sg9
V18475734.xml
p1963
sa(dp1964
g3
VSTD-Fonseca-2008
p1965
sg5
S'PMC2494667'
p1966
sg7
VCD009361 v. 2.2 Colesevelam for type 2 diabetes mellitus.rm5
p1967
sg9
V18458145.xml
p1968
sa(dp1969
g3
VSTD-Sakamoto-2007-_x0028_JFMTC15_x002d_1_x0029_
p1970
sg5
S'PMC2360162'
p1971
sg7
VCD004078 v. 4.0 Postoperative adjuvant chemotherapy in rectal cancer operated for cure..rm5
p1972
sg9
V17375049.xml
p1973
sa(dp1974
g3
VSTD-Taal-2001-_x0028_NACCP_x0029_
p1975
sg5
S'PMC2363941'
p1976
sg7
g1972
sg9
V11720425.xml
p1977
sa(dp1978
g3
VSTD-Leon-2010
p1979
sg5
S'PMC2825497'
p1980
sg7
VCD003318 v. 6.0 Strategies for integrating primary health services in low- and middle-income countries at the point .rm5
p1981
sg9
V20205841.xml
p1982
sa(dp1983
g3
VSTD-Gregson-2007
p1984
sg5
S'PMC1831737'
p1985
sg7
g1981
sg9
V17388666.xml
p1986
sa(dp1987
g3
VSTD-Lorig-2010
p1988
sg5
S'PMC2875437'
p1989
sg7
VCD008776 v. 2.0 Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus.rm5
p1990
sg9
V20299481.xml
p1991
sa(dp1992
g3
VSTD-Quinn-2011
p1993
sg5
S'PMC3161305'
p1994
sg7
g1990
sg9
V21788632.xml
p1995
sa(dp1996
g3
VSTD-Lim-2011
p1997
sg5
S'PMC3024339'
p1998
sg7
g1990
sg9
V21270188.xml
p1999
sa(dp2000
g3
VSTD-Binnie-2007
p2001
sg5
S'PMC1871574'
p2002
sg7
VCD005084 v. 6.0 Interventions for tobacco cessation in the dental setting.rm5
p2003
sg9
V17475005.xml
p2004
sa(dp2005
g3
VSTD-Nohlert-2009
p2006
sg5
S'PMC2685131'
p2007
sg7
g2003
sg9
V19405969.xml
p2008
sa(dp2009
g3
VSTD-van-Sprundel-2005
p2010
sg5
S'PMC2361560'
p2011
sg7
VCD002748 v. 9.2 Prophylactic mastectomy for the prevention of breast cancer.rm5
p2012
sg9
V16052221.xml
p2013
sa(dp2014
g3
VSTD-Kitchener-2009
p2015
sg5
S'PMC2646126'
p2016
sg7
VCD007585 v. 2.0 Lymphadenectomy for the management of endometrial cancer.rm5
p2017
sg9
V19070889.xml
p2018
sa(dp2019
g3
VSTD-Merenstein-2010
p2020
sg5
S'PMC2906750'
p2021
sg7
VCD006895 v. 4.0 Probiotics for preventing acute upper respiratory tract infections.rm5
p2022
sg9
V20485304.xml
p2023
sa(dp2024
g3
VSTD-West-2011
p2025
sg5
S'PMC3083335'
p2026
sg7
g2022
sg9
V21477383.xml
p2027
sa(dp2028
g3
VSTD-Mahalanabis-2008
p2029
sg5
S'PMC2396289'
p2030
sg7
VCD008603 v. 3.0 Oral vaccines for preventing cholera.rm5
p2031
sg9
V18523643.xml
p2032
sa(dp2033
g3
VSTD-UK-PRECISE
p2034
sg5
S'PMC3446875'
p2035
sg7
VCD009671 v. 2.0 Selenium supplementation for the primary prevention of cardiovascular disease.rm5
p2036
sg9
V23028897.xml
p2037
sa(dp2038
g3
VSTD-ANRS-1265
p2039
sg5
S'PMC1262556'
p2040
sg7
VCD003362 v. 8.0 Male circumcision for prevention of heterosexual acquisition of HIV in men.rm5
p2041
sg9
V16231970.xml
p2042
sa(dp2043
g3
VSTD-Dube-1981
p2044
sg5
S'PMC3012941'
p2045
sg7
VCD003834 v. 5.0 Lithium for schizophrenia.rm5
p2046
sg9
V22058537.xml
p2047
sa(dp2048
g3
VSTD-Kuna-2007
p2049
sg5
S'PMC1920547'
p2050
sg7
VCD007694 v. 5.0 Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmet.rm5
p2051
sg9
V17362472.xml
p2052
sa(dp2053
g3
VSTD-Maspero-2010
p2054
sg5
S'PMC2993043'
p2055
sg7
g2051
sg9
V20874458.xml
p2056
sa(dp2057
g3
VSTD-Jimenez-2007
p2058
sg5
S'PMC2246206'
p2059
sg7
VCD001886 v. 8.0 Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.rm5
p2060
sg9
V17988379.xml
p2061
sa(dp2062
g3
VSTD-Apostolakis-2008
p2063
sg5
S'PMC2287179'
p2064
sg7
g2060
sg9
V18361800.xml
p2065
sa(dp2066
g3
VSTD-Peng-2011
p2067
sg5
S'PMC3177872'
p2068
sg7
VCD004323 v. 8.0 Quality of life after rectal resection for cancer with or without permanent colostomy..rm5
p2069
sg9
V21835046.xml
p2070
sa(dp2071
g3
VSTD-Allal-2000
p2072
sg5
S'PMC2363346'
p2073
sg7
g2069
sg9
V10735495.xml
p2074
sa(dp2075
g3
VSTD-SPHERE
p2076
sg5
S'PMC2770592'
p2077
sg7
VCD006772 v. 4.0 Service organisation for the secondary prevention of ischaemic heart disease in primary care.rm5
p2078
sg9
V19875426.xml
p2079
sa(dp2080
g3
VSTD-Pilu-2007
p2081
sg5
S'PMC1976311'
p2082
sg7
VCD004366 v. 11.2 Exercise for depression.rm5
p2083
sg9
V17620123.xml
p2084
sa(dp2085
g3
VSTD-Chaney-2011
p2086
sg5
S'PMC3219630'
p2087
sg7
VCD006525 v. 5.0 Collaborative care for depression and anxiety problems.rm5
p2088
sg9
V22032247.xml
p2089
sa(dp2090
g3
VSTD-Landis-2007
p2091
sg5
S'PMC1838423'
p2092
sg7
g2088
sg9
V17338822.xml
p2093
sa(dp2094
g3
VSTD-Richards-2012
p2095
sg5
S'PMC2770465'
p2096
sg7
g2088
sg9
V19832996.xml
p2097
sa(dp2098
g3
VSTD-Waitzkin-2011
p2099
sg5
S'PMC3051073'
p2100
sg7
g2088
sg9
V20882400.xml
p2101
sa(dp2102
g3
VSTD-Ell-2010
p2103
sg5
S'PMC2845010'
p2104
sg7
g2088
sg9
V20097780.xml
p2105
sa(dp2106
g3
VSTD-Saxena-2009
p2107
sg5
S'PMC2900101'
p2108
sg7
VCD009107 v. 4.0 Intracutaneous or subcutaneous sterile water injection compared with blinded controls for pain manag.rm5
p2109
sg9
V20640118.xml
p2110
sa(dp2111
g3
VSTD-Yildiz-2002
p2112
sg5
S'PMC125315'
p2113
sg7
VCD002243 v. 5.2 Corticosteroids for treating severe sepsis and septic shock.rm5
p2114
sg9
V12133187.xml
p2115
sa(dp2116
g3
VSTD-Uludag-2009
p2117
sg5
S'PMC3015970'
p2118
sg7
VCD005265 v. 3.3 Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy.rm5
p2119
sg9
V19793473.xml
p2120
sa(dp2121
g3
VSTD-Spittle-2009a
p2122
sg5
S'PMC2797495'
p2123
sg7
VCD005495 v. 5.2 Early developmental intervention programmes post-hospital discharge to prevent motor and cognitive i.rm5
p2124
sg9
V19954550.xml
p2125
sa(dp2126
g3
VSTD-Taniguchi-2009
p2127
sg5
S'PMC2688118'
p2128
sg7
VCD009235 v. 5.3 Automated versus non-automated weaning for reducing the duration of mechanical ventilation for criti.rm5
p2129
sg9
V19171056.xml
p2130
sa(dp2131
g3
VSTD-Houghton-2007
p2132
sg5
S'PMC1971055'
p2133
sg7
VCD005535 v. 3.0 Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticost.rm5
p2134
sg9
V17629923.xml
p2135
sa(dp2136
g3
VSTD-Spiro-1989
p2137
sg5
S'PMC2247136'
p2138
sg7
VCD001990 v. 12.0 Chemotherapy versus best supportive care for extensive small cell lung cancer.rm5
p2139
sg9
V2540788.xml
p2140
sa(dp2141
g3
VSTD-Wintzen-2007
p2142
sg5
S'PMC1915648'
p2143
sg7
VCD003218 v. 9.0 Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.rm5
p2144
sg9
V17285226.xml
p2145
sa(dp2146
g3
VSTD-Koninckx-2008
p2147
sg5
S'PMC2517154'
p2148
sg7
VCD008088 v. 6.0 Anti-TNF- treatment for pelvic pain associated with endometriosis.rm5
p2149
sg9
V18556683.xml
p2150
sa(dp2151
g3
VSTD-Dondorp-2010
p2152
sg5
S'PMC3033534'
p2153
sg7
VCD005967 v. 9.3 Artesunate versus quinine for treating severe malaria.rm5
p2154
sg9
V21062666.xml
p2155
sa(dp2156
g3
VSTD-De-Jong-2008
p2157
sg5
S'PMC2194921'
p2158
sg7
VCD006378 v. 3.0 Aspirin steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseas.rm5
p2159
sg9
V18213383.xml
p2160
sa(dp2161
g3
VSTD-Amirabdollahian-2007
p2162
sg5
S'PMC1819386'
p2163
sg7
VCD006876 v. 4.0 Electromechanical and robot-assisted arm training for improving generic activities of daily living .rm5
p2164
sg9
V17309791.xml
p2165
sa(dp2166
g3
VSTD-Kahn-2006
p2167
sg5
S'PMC1550245'
p2168
sg7
g2164
sg9
V16790067.xml
p2169
sa(dp2170
g3
VSTD-Murthy-1991
p2171
sg5
S'PMC2988295'
p2172
sg7
VCD007139 v. 3.0 Alprazolam for depression.rm5
p2173
sg9
V21897464.xml
p2174
sa(dp2175
g3
VSTD-Jhanji-2010
p2176
sg5
S'PMC2945135'
p2177
sg7
VCD004082 v. 11.0 Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery.rm5
p2178
sg9
V20698956.xml
p2179
sa(dp2180
g3
VSTD-Cecconi-2011
p2181
sg5
S'PMC3218998'
p2182
sg7
g2178
sg9
V21624138.xml
p2183
sa(dp2184
g3
VSTD-Pearse-2005
p2185
sg5
S'PMC1414018'
p2186
sg7
g2178
sg9
V16356219.xml
p2187
sa(dp2188
g3
VSTD-Mayer-2010
p2189
sg5
S'PMC2875533'
p2190
sg7
g2178
sg9
V20156348.xml
p2191
sa(dp2192
g3
VSTD-Cote-1998
p2193
sg5
S'PMC2063039'
p2194
sg7
VCD007091 v. 5.0 5-alpha-reductase inhibitors for prostate cancer prevention.rm5
p2195
sg9
V9703292.xml
p2196
sa(dp2197
g3
VSTD-Unrod-2007
p2198
sg5
S'PMC1829425'
p2199
sg7
VCD000214 v. 10.5 Training health professionals in smoking cessation.rm5
p2200
sg9
V17372796.xml
p2201
sa(dp2202
g3
VSTD-Clifford-2002
p2203
sg5
S'PMC126226'
p2204
sg7
VMR000012 v. 6.2 Randomisation to protect against selection bias in healthcare trials.rm5
p2205
sg9
V12213183.xml
p2206
sa(dp2207
g3
VSTD-Leehey-2009
p2208
sg5
S'PMC2796994'
p2209
sg7
VCD003236 v. 7.0 Exercise training for adults with chronic kidney disease.rm5
p2210
sg9
V20003224.xml
p2211
sa(dp2212
g3
VSTD-Baer-2005
p2213
sg5
S'PMC1201146'
p2214
sg7
VCD007400 v. 4.0 Topical NSAIDs for chronic musculoskeletal pain in adults.rm5
p2215
sg9
V16086839.xml
p2216
sa(dp2217
g3
VSTD-Cowett-1977
p2218
sg5
S'PMC2595562'
p2219
sg7
VCD004697 v. 6.0 Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery cathete.rm5
p2220
sg9
V602256.xml
p2221
sa(dp2222
g3
VSTD-Stepnowsky-2007
p2223
sg5
S'PMC1874716'
p2224
sg7
VCD007736 v. 2.0 Educational supportive and behavioural interventions to improve usage of continuous positive airway.rm5
p2225
sg9
V17513285.xml
p2226
sa(dp2227
g3
VSTD-Halpern-2008
p2228
sg5
S'PMC2582655'
p2229
sg7
VCD007961 v. 2.0 Topical microbicides for prevention of sexually transmitted infections.rm5
p2230
sg9
V19023429.xml
p2231
sa(dp2232
g3
VSTD-Peterson-2007
p2233
sg5
S'PMC2129116'
p2234
sg7
g2230
sg9
V18091987.xml
p2235
sa(dp2236
g3
VSTD-McCormack-2010
p2237
sg5
S'PMC2956883'
p2238
sg7
g2230
sg9
V20851460.xml
p2239
sa(dp2240
g3
VSTD-Feldblum-2008
p2241
sg5
S'PMC2190795'
p2242
sg7
g2230
sg9
V18213382.xml
p2243
sa(dp2244
g3
VSTD-Ahmedzai-2004
p2245
sg5
S'PMC2409543'
p2246
sg7
VCD004769 v. 7.0 Oxygen therapy for dyspnoea in adults.rm5
p2247
sg9
V14735178.xml
p2248
sa(dp2249
g3
VSTD-Innes-2007
p2250
sg5
S'PMC2265270'
p2251
sg7
VCD003808 v. 6.0 Operative caries management in adults and children.rm5
p2252
sg9
V18096042.xml
p2253
sa(dp2254
g3
VSTD-Londahl-2010
p2255
sg5
S'PMC2858204'
p2256
sg7
VCD004123 v. 9.2 Hyperbaric oxygen therapy for chronic wounds.rm5
p2257
sg9
V20427683.xml
p2258
sa(dp2259
g3
VSTD-Nguyen-2008
p2260
sg5
S'PMC2483918'
p2261
sg7
VCD007718 v. 3.0 Telehealthcare for chronic obstructive pulmonary disease.rm5
p2262
sg9
V18417444.xml
p2263
sa(dp2264
g3
VSTD-GICOG
p2265
sg5
S'PMC2360651'
p2266
sg7
VCD003175 v. 6.0 Adjuvant chemotherapy for endometrial cancer after hysterectomy.rm5
p2267
sg9
V16868539.xml
p2268
sa(dp2269
g3
VSTD-Oosterhof-2006
p2270
sg5
S'PMC3476076'
p2271
sg7
VCD003222 v. 5.0 Transcutaneous electrical nerve stimulation (TENS) for chronic pain.rm5
p2272
sg9
V16897618.xml
p2273
sa(dp2274
g3
VSTD-Van-Koningsveld-2004
p2275
sg5
S'PMC2778673'
p2276
sg7
VCD001446 v. 14.0 Corticosteroids for Guillain-Barr syndrome.rm5
p2277
sg9
V17426908.xml
p2278
sa(dp2279
g3
VSTD-Worth-2009
p2280
sg5
S'PMC2720945'
p2281
sg7
VCD001287 v. 10.6 Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.rm5
p2282
sg9
V19624838.xml
p2283
sa(dp2284
g3
VSTD-Moroni-1996
p2285
sg5
S'PMC2074576'
p2286
sg7
VCD007881 v. 3.0 Interventions for cough in cancer.rm5
p2287
sg9
V8688342.xml
p2288
sa(dp2289
g3
VSTD-Webster-2008
p2290
sg5
S'PMC2483870'
p2291
sg7
VCD007798 v. 3.0 Clinically-indicated replacement versus routine replacement of peripheral venous catheters.rm5
p2292
sg9
V18614482.xml
p2293
sa(dp2294
g3
VSTD-Rickard-2010
p2295
sg5
S'PMC2944158'
p2296
sg7
g2292
sg9
V20831782.xml
p2297
sa(dp2298
g3
VSTD-Henker-2007a
p2299
sg5
S'PMC1802727'
p2300
sg7
VCD003048 v. 6.0 Probiotics for treating acute infectious diarrhoea.rm5
p2301
sg9
V17287932.xml
p2302
sa(dp2303
g3
VSTD-Delvaux-2004
p2304
sg5
S'PMC2395320'
p2305
sg7
VCD002892 v. 7.0 Preventing occupational stress in healthcare workers.rm5
p2306
sg9
V14710215.xml
p2307
sa(dp2308
g3
VSTD-Tehraninejad-2010
p2309
sg5
S'PMC3302709'
p2310
sg7
VCD002808 v. 6.0 Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary.rm5
p2311
sg9
V22427771.xml
p2312
sa(dp2313
g3
VSTD-Turpeinen-2008
p2314
sg5
S'PMC2532957'
p2315
sg7
VCD009611 v. 3.0 Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.rm5
p2316
sg9
V17634183.xml
p2317
sa(dp2318
g3
VSTD-ICSS-2010
p2319
sg5
S'PMC2849002'
p2320
sg7
VCD000515 v. 6.2 Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis.rm5
p2321
sg9
V20189239.xml
p2322
sa(dp2323
g3
VSTD-Lenssen-2008
p2324
sg5
S'PMC2386789'
p2325
sg7
VCD004260 v. 8.0 Continuous passive motion following total knee arthroplasty in people with arthritis.rm5
p2326
sg9
V18442423.xml
p2327
sa(dp2328
g3
VSTD-Fern_x00e1_ndez-2009
p2329
sg5
S'PMC2621339'
p2330
sg7
VCD005992 v. 4.0 Legislative smoking bans for reducing secondhand smoke exposure smoking prevalence and tobacco cons.rm5
p2331
sg9
V19165321.xml
p2332
sa(dp2333
g3
VSTD-Gal_x00e1_n-2007
p2334
sg5
S'PMC2034550'
p2335
sg7
g2331
sg9
V17760974.xml
p2336
sa(dp2337
g3
VSTD-Alsaedi-2009
p2338
sg5
S'PMC2813645'
p2339
sg7
VCD001069 v. 7.0 Sucrose for analgesia in newborn infants undergoing painful procedures.rm5
p2340
sg9
V19448377.xml
p2341
sa(dp2342
g3
VSTD-Slater-2010
p2343
sg5
S'PMC2958259'
p2344
sg7
g2340
sg9
V20817247.xml
p2345
sa(dp2346
g3
VSTD-Tonnel-2008
p2347
sg5
S'PMC2629970'
p2348
sg7
VCD009285 v. 4.0 Tiotropium versus placebo for chronic obstructive pulmonary disease.rm5
p2349
sg9
V18686739.xml
p2350
sa(dp2351
g3
VSTD-Bateman-2010b
p2352
sg5
S'PMC2921687'
p2353
sg7
g2349
sg9
V20714373.xml
p2354
sa(dp2355
g3
VSTD-Freeman-2007
p2356
sg5
S'PMC1913915'
p2357
sg7
g2349
sg9
V17605774.xml
p2358
sa(dp2359
g3
VSTD-Trooster-2011
p2360
sg5
S'PMC3078679'
p2361
sg7
g2349
sg9
V21503263.xml
p2362
sa(dp2363
g3
VSTD-Cooper-2010
p2364
sg5
S'PMC2981152'
p2365
sg7
g2349
sg9
V21103404.xml
p2366
sa(dp2367
g3
VSTD-Choung-2008
p2368
sg5
S'PMC2671765'
p2369
sg7
VCD003423 v. 4.2 Antihistamines andor decongestants for otitis media with effusion (OME) in children.rm5
p2370
sg9
V19434268.xml
p2371
sa(dp2372
g3
VSTD-Bertuzzi-2003
p2373
sg5
S'PMC2394317'
p2374
sg7
VCD008216 v. 3.0 Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomy.rm5
p2375
sg9
V14520438.xml
p2376
sa(dp2377
g3
VSTD-Leung-2006
p2378
sg5
S'PMC1804104'
p2379
sg7
VCD005457 v. 7.0 Carbetocin for preventing postpartum haemorrhage.rm5
p2380
sg9
V17176279.xml
p2381
sa(dp2382
g3
VSTD-Scabini-2010
p2383
sg5
S'PMC2873340'
p2384
sg7
VCD001544 v. 8.0 Mechanical bowel preparation for elective colorectal surgery.rm5
p2385
sg9
V20433721.xml
p2386
sa(dp2387
g3
VSTD-Syed-2006
p2388
sg5
S'PMC3001155'
p2389
sg7
VCD007754 v. 3.0 Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and.rm5
p2390
sg9
V17591348.xml
p2391
sa(dp2392
g3
VSTD-Bari-2006
p2393
sg5
S'PMC3001156'
p2394
sg7
g2390
sg9
V17591349.xml
p2395
sa(dp2396
g3
VSTD-Tweyongyere-2009-UGA
p2397
sg5
S'PMC2666740'
p2398
sg7
VCD000528 v. 8.4 Drugs for treating Schistosoma mansoni infection.rm5
p2399
sg9
V19296834.xml
p2400
sa(dp2401
g3
VSTD-Olliaro-2011-TZA
p2402
sg5
S'PMC3114749'
p2403
sg7
g2399
sg9
V21695161.xml
p2404
sa(dp2405
g3
VSTD-Olliaro-2011-MRT
p2406
sg5
S'PMC3114749'
p2407
sg7
g2399
sg9
V21695161.xml
p2408
sa(dp2409
g3
VSTD-Olliaro-2011-BRA
p2410
sg5
S'PMC3114749'
p2411
sg7
g2399
sg9
V21695161.xml
p2412
sa(dp2413
g3
VSTD-Bergstrom-2009
p2414
sg5
S'PMC2759981'
p2415
sg7
VCD009514 v. 1.0 Relaxation techniques for pain management in labour.rm5
p2416
sg9
V19538406.xml
p2417
sa(dp2418
g3
VSTD-Fiocchi-1994
p2419
sg5
S'PMC2365600'
p2420
sg7
VCD004108 v. 9.0 Nedocromil sodium for chronic asthma in children.rm5
p2421
sg9
V18475604.xml
p2422
sa(dp2423
g3
VSTD-Kouyate-2008
p2424
sg5
S'PMC2287184'
p2425
sg7
VCD004015 v. 6.3 Lay health workers in primary and community health care for maternal and child health and the manage.rm5
p2426
sg9
V18364043.xml
p2427
sa(dp2428
g3
VSTD-MacArthur-2009
p2429
sg5
S'PMC2636685'
p2430
sg7
g2426
sg9
V19181730.xml
p2431
sa(dp2432
g3
VSTD-Bari-2006
p2433
sg5
S'PMC3001156'
p2434
sg7
g2426
sg9
V17591349.xml
p2435
sa(dp2436
g3
VSTD-Dennis-2009
p2437
sg5
S'PMC2628301'
p2438
sg7
g2426
sg9
V19147637.xml
p2439
sa(dp2440
g3
VSTD-Zaman-2008
p2441
sg5
S'PMC2740673'
p2442
sg7
g2426
sg9
V18686554.xml
p2443
sa(dp2444
g3
VSTD-Karatzas-2002
p2445
sg5
S'PMC153443'
p2446
sg7
VCD001090 v. 10.5 Intravenous immunoglobulin for treating sepsis severe sepsis and septic shock.rm5
p2447
sg9
V12512504.xml
p2448
sa(dp2449
g3
VSTD-Tugrul-2002
p2450
sg5
S'PMC125317'
p2451
sg7
g2447
sg9
V12225613.xml
p2452
sa(dp2453
g3
VSTD-Campbell-2008
p2454
sg5
S'PMC2387195'
p2455
sg7
VCD001293 v. 13.0 School-based programmes for preventing smoking.rm5
p2456
sg9
V18468543.xml
p2457
sa(dp2458
g3
VSTD-Johnson-2009
p2459
sg5
S'PMC2681204'
p2460
sg7
g2456
sg9
V19440519.xml
p2461
sa(dp2462
g3
VSTD-Edwards-1996
p2463
sg5
S'PMC2364515'
p2464
sg7
VCD000054 v. 10.0 Interventions for treating genital chlamydia trachomatis infection in pregnancy.rm5
p2465
sg9
V18476121.xml
p2466
sa(dp2467
g3
VSTD-Martin-1997
p2468
sg5
S'PMC2364533'
p2469
sg7
g2465
sg9
V18476128.xml
p2470
sa(dp2471
g3
VSTD-Rosenn-1995
p2472
sg5
S'PMC2364446'
p2473
sg7
g2465
sg9
V18476049.xml
p2474
sa(dp2475
g3
VSTD-Turrentine-1995
p2476
sg5
S'PMC2364394'
p2477
sg7
g2465
sg9
V18475393.xml
p2478
sa(dp2479
g3
VSTD-Khanna-2005
p2480
sg5
S'PMC1156915'
p2481
sg7
VCD006099 v. 6.0 Wound drains following thyroid surgery.rm5
p2482
sg9
V15946379.xml
p2483
sa(dp2484
g3
VSTD-Smithuis-2010-MMR
p2485
sg5
S'PMC2947715'
p2486
sg7
VCD008492 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.rm5
p2487
sg9
V20832366.xml
p2488
sa(dp2489
g3
VSTD-Awab-2010-AFG
p2490
sg5
S'PMC2864284'
p2491
sg7
g2487
sg9
V20409302.xml
p2492
sa(dp2493
g3
VSTD-Hutagalung-2005-THA
p2494
sg5
S'PMC1261533'
p2495
sg7
g2487
sg9
V16179089.xml
p2496
sa(dp2497
g3
VSTD-Poravuth-2010-ASIA
p2498
sg5
S'PMC3022577'
p2499
sg7
g2487
sg9
V21267072.xml
p2500
sa(dp2501
g3
VSTD-Kralikova-2009
p2502
sg5
S'PMC2792228'
p2503
sg7
VCD005231 v. 5.0 Interventions to reduce harm from continued tobacco use.rm5
p2504
sg9
V19943947.xml
p2505
sa(dp2506
g3
VSTD-Thorstensson-2005
p2507
sg5
S'PMC1187893'
p2508
sg7
VCD004376 v. 5.0 Exercise for osteoarthritis of the knee.rm5
p2509
sg9
V15924620.xml
p2510
sa(dp2511
g3
VSTD-Zorlu-2005
p2512
sg5
S'PMC3015649'
p2513
sg7
VCD006655 v. 4.0 Laparoscopy versus laparotomy for the management of early stage endometrial cancer.rm5
p2514
sg9
V16381364.xml
p2515
sa(dp2516
g3
VSTD-Misra-2007
p2517
sg5
S'PMC3476139'
p2518
sg7
VCD008039 v. 4.0 Ibuprofen with or without an antiemetic for acute migraine headaches in adults.rm5
p2519
sg9
V17563841.xml
p2520
sa(dp2521
g3
VSTD-Chan-2008
p2522
sg5
S'PMC2671976'
p2523
sg7
VCD007315 v. 2.0 Perioperative glycaemic control for diabetic patients undergoing surgery.rm5
p2524
sg9
V19142552.xml
p2525
sa(dp2526
g3
VSTD-Li-2008
p2527
sg5
S'PMC2597744'
p2528
sg7
VCD008651 v. 3.0 Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in .rm5
p2529
sg9
V19081791.xml
p2530
sa(dp2531
g3
VSTD-Wattchow-2006
p2532
sg5
S'PMC2361245'
p2533
sg7
VCD002200 v. 5.0 Follow-up strategies for patients treated for non-metastatic colorectal cancer.rm5
p2534
sg9
V16622437.xml
p2535
sa(dp2536
g3
VSTD-Russell_x002d_Jones-2009
p2537
sg5
S'PMC2744824'
p2538
sg7
VCD002967 v. 10.0 Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.rm5
p2539
sg9
V19688338.xml
p2540
sa(dp2541
g3
VSTD-Home-2007
p2542
sg5
S'PMC1974817'
p2543
sg7
g2539
sg9
V17403121.xml
p2544
sa(dp2545
g3
VSTD-Zinman-2009
p2546
sg5
S'PMC2699702'
p2547
sg7
g2539
sg9
V19289857.xml
p2548
sa(dp2549
g3
VSTD-List-2009
p2550
sg5
S'PMC2660449'
p2551
sg7
g2539
sg9
V19114612.xml
p2552
sa(dp2553
g3
VSTD-Nauck-2009b
p2554
sg5
S'PMC2699710'
p2555
sg7
g2539
sg9
V19366970.xml
p2556
sa(dp2557
g3
VSTD-Nauck-2009a
p2558
sg5
S'PMC2606836'
p2559
sg7
g2539
sg9
V18931095.xml
p2560
sa(dp2561
g3
VSTD-Melfsen-2011
p2562
sg5
S'PMC3058082'
p2563
sg7
VCD004690 v. 6.0 Cognitive behavioural therapy for anxiety disorders in children and adolescents.rm5
p2564
sg9
V21356037.xml
p2565
sa(dp2566
g3
VSTD-T_x00f8_nnesen-2012
p2567
sg5
S'PMC3432241'
p2568
sg7
VCD000146 v. 19.3 Nicotine replacement therapy for smoking cessation.rm5
p2569
sg9
V22323576.xml
p2570
sa(dp2571
g3
VSTD-Rosenstock-2008
p2572
sg5
S'PMC2235909'
p2573
sg7
VCD006383 v. 3.2 Insulin detemir versus insulin glargine for type 2 diabetes mellitus.rm5
p2574
sg9
V18204830.xml
p2575
sa(dp2576
g3
VSTD-Swinnen-2010a
p2577
sg5
S'PMC2875419'
p2578
sg7
g2574
sg9
V20200301.xml
p2579
sa(dp2580
g3
VSTD-Westerbeek-2010
p2581
sg5
S'PMC2579424'
p2582
sg7
VCD006474 v. 4.0 Prebiotics in infants for prevention of allergy.rm5
p2583
sg9
V18947426.xml
p2584
sa(dp2585
g3
VSTD-Emet-2004
p2586
sg5
S'PMC522835'
p2587
sg7
VCD006616 v. 3.2 N-acetylcysteine for sepsis and systemic inflammatory response in adults.rm5
p2588
sg9
V15312215.xml
p2589
sa(dp2590
g3
VSTD-Kuijper-2009
p2591
sg5
S'PMC2758937'
p2592
sg7
VCD004250 v. 8.7 Exercises for mechanical neck disorders.rm5
p2593
sg9
V19812130.xml
p2594
sa(dp2595
g3
VSTD-Martel-2011
p2596
sg5
S'PMC3045999'
p2597
sg7
g2593
sg9
V21303529.xml
p2598
sa(dp2599
g3
VSTD-Str_x00f6_hlein-2009
p2600
sg5
S'PMC2644666'
p2601
sg7
VCD007287 v. 2.0 Antigen-specific active immunotherapy for ovarian cancer.rm5
p2602
sg9
V19216794.xml
p2603
sa(dp2604
g3
VSTD-Manegold-2003
p2605
sg5
S'PMC2361263'
p2606
sg7
VCD002140 v. 7.0 Concurrent chemoradiotherapy in non-small cell lung cancer.rm5
p2607
sg9
V16641904.xml
p2608
sa(dp2609
g3
VSTD-van-der-Kooi-2007
p2610
sg5
S'PMC2779375'
p2611
sg7
VCD003908 v. 8.0 Rehabilitation interventions for foot drop in neuromuscular disease.rm5
p2612
sg9
V17361345.xml
p2613
sa(dp2614
g3
VSTD-Gregson-2007
p2615
sg5
S'PMC1831737'
p2616
sg7
VCD001220 v. 8.2 Population-based biomedical sexually transmitted infection control interventions for reducing HIV in.rm5
p2617
sg9
V17388666.xml
p2618
sa(dp2619
g3
VSTD-Echeverry-2009
p2620
sg5
S'PMC2782968'
p2621
sg7
VCD008381 v. 2.2 Psychological and pharmacological interventions for depression in patients with diabetes mellitus an.rm5
p2622
sg9
V19729522.xml
p2623
sa(dp2624
g3
VSTD-Paile_x002d_Hyv_x00e4_rinen-2007
p2625
sg5
S'PMC1914073'
p2626
sg7
g2622
sg9
V17570858.xml
p2627
sa(dp2628
g3
VSTD-Paile_x002d_Hyv_x00e4_rinen-2003
p2629
sg5
S'PMC165418'
p2630
sg7
g2622
sg9
V12747810.xml
p2631
sa(dp2632
g3
VSTD-van-Bastelaar-2011
p2633
sg5
S'PMC3024341'
p2634
sg7
g2622
sg9
V21216855.xml
p2635
sa(dp2636
g3
VSTD-Campbell-1991
p2637
sg5
S'PMC2448633'
p2638
sg7
VCD004125 v. 6.0 Drugs for preventing postoperative nausea and vomiting.rm5
p2639
sg9
V1853495.xml
p2640
sa(dp2641
g3
VSTD-Dabbous-1998
p2642
sg5
S'PMC3015295'
p2643
sg7
g2639
sg9
V9876753.xml
p2644
sa(dp2645
g3
VSTD-_x0030_13-Papanikolaou-2004
p2646
sg5
S'PMC524504'
p2647
sg7
VCD000941 v. 13.0 Vaginal misoprostol for cervical ripening and induction of labour.rm5
p2648
sg9
V15450119.xml
p2649
sa(dp2650
g3
VSTD-RIOTT-2010
p2651
sg5
S'PMC1613238'
p2652
sg7
VCD003410 v. 20.2 Heroin maintenance for chronic heroin-dependent individuals.rm5
p2653
sg9
V17002810.xml
p2654
sa(dp2655
g3
VSTD-McElhinney-2000
p2656
sg5
S'PMC2449154'
p2657
sg7
VCD000006 v. 8.0 Absorbable suture materials for primary repair of episiotomy and second degree tears.rm5
p2658
sg9
V10881642.xml
p2659
sa(dp2660
g3
VSTD-Strychar-2009
p2661
sg5
S'PMC2732152'
p2662
sg7
VCD002137 v. 8.2 Reduced or modified dietary fat for preventing cardiovascular disease.rm5
p2663
sg9
V19542011.xml
p2664
sa(dp2665
g3
VSTD-Barrowman-2003
p2666
sg5
S'PMC212708'
p2667
sg7
VMR000023 v. 4.2 When and how to update systematic reviews.rm5
p2668
sg9
V12877755.xml
p2669
sa(dp2670
g3
VSTD-Neuhaus-2009
p2671
sg5
S'PMC2634726'
p2672
sg7
VCD003869 v. 10.0 Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.rm5
p2673
sg9
V19127261.xml
p2674
sa(dp2675
g3
VSTD-McKay-2008
p2676
sg5
S'PMC2630830'
p2677
sg7
VCD002295 v. 9.0 Exercise interventions for smoking cessation.rm5
p2678
sg9
V19017582.xml
p2679
sa(dp2680
g3
VSTD-Kylmala-1997
p2681
sg5
S'PMC2228066'
p2682
sg7
VCD006250 v. 4.0 Bisphosphonates for advanced prostate cancer.rm5
p2683
sg9
V9328156.xml
p2684
sa(dp2685
g3
VSTD-Opiyo-2008
p2686
sg5
S'PMC2229665'
p2687
sg7
VCD007071 v. 4.0 In-service training for health professionals to improve care of the seriously ill newborn or child i.rm5
p2688
sg9
V18270586.xml
p2689
sa(dp2690
g3
VSTD-Sculier-2001
p2691
sg5
S'PMC2363948'
p2692
sg7
VCD007107 v. 2.4 Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in ca.rm5
p2693
sg9
V11720426.xml
p2694
sa(dp2695
g3
VSTD-Vedder-2007
p2696
sg5
S'PMC1913555'
p2697
sg7
VCD006663 v. 7.0 Enzyme replacement therapy for Anderson-Fabry disease.rm5
p2698
sg9
V17622343.xml
p2699
sa(dp2700
g3
VSTD-Westlake-2009
p2701
sg5
S'PMC2708184'
p2702
sg7
VCD006185 v. 5.0 Electromechanical-assisted training for walking after stroke.rm5
p2703
sg9
V19523207.xml
p2704
sa(dp2705
g3
VSTD-Gill-2011
p2706
sg5
S'PMC3032994'
p2707
sg7
VCD005460 v. 6.0 Traditional birth attendant training for improving health behaviours and pregnancy outcomes.rm5
p2708
sg9
V21292711.xml
p2709
sa(dp2710
g3
VSTD-Kercsmar-2006
p2711
sg5
S'PMC1626393'
p2712
sg7
VCD007897 v. 2.2 Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract sym.rm5
p2713
sg9
V17035145.xml
p2714
sa(dp2715
g3
VSTD-Cremin-2010
p2716
sg5
S'PMC2865634'
p2717
sg7
VCD001224 v. 5.0 Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countrie.rm5
p2718
sg9
V19623481.xml
p2719
sa(dp2720
g3
VSTD-Swoboda-2010
p2721
sg5
S'PMC2924376'
p2722
sg7
VCD006282 v. 4.0 Drug treatment for spinal muscular atrophy types II and III.rm5
p2723
sg9
V20808854.xml
p2724
sa(dp2725
g3
VSTD-Schiff-2008
p2726
sg5
S'PMC2564802'
p2727
sg7
VCD007277 v. 3.0 Abatacept for rheumatoid arthritis.rm5
p2728
sg9
V18055472.xml
p2729
sa(dp2730
g3
VSTD-Combe-2006
p2731
sg5
S'PMC2689524'
p2732
sg7
VCD004525 v. 6.51 Etanercept for the treatment of rheumatoid arthritis.rm5
p2733
sg9
V18794178.xml
p2734
sa(dp2735
g3
VSTD-Ietswaart-2011
p2736
sg5
S'PMC3097892'
p2737
sg7
VCD008449 v. 2.0 Mirror therapy for improving motor function after stroke.rm5
p2738
sg9
V21515905.xml
p2739
sa(dp2740
g3
VSTD-Yun-2010
p2741
sg5
S'PMC3309215'
p2742
sg7
g2738
sg9
V22506139.xml
p2743
sa(dp2744
g3
VSTD-Hurley-2007
p2745
sg5
S'PMC2673355'
p2746
sg7
VCD005956 v. 3.0 Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.rm5
p2747
sg9
V17907147.xml
p2748
sa(dp2749
g3
VSTD-Nour-2006
p2750
sg5
S'PMC1525193'
p2751
sg7
g2747
sg9
V16734904.xml
p2752
sa(dp2753
g3
VSTD-Ersek-2004
p2754
sg5
S'PMC509247'
p2755
sg7
g2747
sg9
V15285783.xml
p2756
sa(dp2757
g3
VSTD-Smeets-2006
p2758
sg5
S'PMC1382224'
p2759
sg7
g2747
sg9
V16426449.xml
p2760
sa(dp2761
g3
VSTD-Forsetlund-2003
p2762
sg5
S'PMC153535'
p2763
sg7
VCD003030 v. 6.5 Continuing education meetings and workshops effects on professional practice and health care outcom.rm5
p2764
sg9
V12694632.xml
p2765
sa(dp2766
g3
VSTD-Chappell-2008
p2767
sg5
S'PMC2840539'
p2768
sg7
VCD010292 v. 3.0 Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.rm5
p2769
sg9
V20428412.xml
p2770
sa(dp2771
g3
VSTD-Smithuis-2010
p2772
sg5
S'PMC2947715'
p2773
sg7
VCD008152 v. 2.4 Primaquine for reducing Plasmodium falciparum transmission.rm5
p2774
sg9
V20832366.xml
p2775
sa(dp2776
g3
VSTD-Kolaczinski-2012
p2777
sg5
S'PMC3269419'
p2778
sg7
g2774
sg9
V22303437.xml
p2779
sa(dp2780
g3
VSTD-El_x002d_Sayed-2007
p2781
sg5
S'PMC2111052'
p2782
sg7
g2774
sg9
V18074034.xml
p2783
sa(dp2784
g3
VSTD-Ledermann-2006
p2785
sg5
S'PMC1665467'
p2786
sg7
g2774
sg9
V17105658.xml
p2787
sa(dp2788
g3
VSTD-Shekalaghe-2007
p2789
sg5
S'PMC1995753'
p2790
sg7
g2774
sg9
V17925871.xml
p2791
sa(dp2792
g3
VSTD-Mistiaen-2009
p2793
sg5
S'PMC2924330'
p2794
sg7
VCD001735 v. 17.4 Support surfaces for pressure ulcer prevention.rm5
p2795
sg9
V20687915.xml
p2796
sa(dp2797
g3
VSTD-PITCH-2012
p2798
sg5
S'PMC3420230'
p2799
sg7
VCD000493 v. 8.0 Interventions for treating cholestasis in pregnancy.rm5
p2800
sg9
V22695903.xml
p2801
sa(dp2802
g3
VSTD-CLOTS-2009
p2803
sg5
S'PMC2692021'
p2804
sg7
VCD001922 v. 6.0 Physical methods for preventing deep vein thrombosis in stroke.rm5
p2805
sg9
V19477503.xml
p2806
sa(dp2807
g3
VSTD-Mok-2007
p2808
sg5
S'PMC2656338'
p2809
sg7
VCD004744 v. 6.0 Rivastigmine for vascular cognitive impairment.rm5
p2810
sg9
V19300631.xml
p2811
sa(dp2812
g3
VSTD-Carlini-2012
p2813
sg5
S'PMC3438078'
p2814
sg7
VCD009187 v. 2.0 Interventions for recruiting smokers into cessation programmes.rm5
p2815
sg9
V22768793.xml
p2816
sa(dp2817
g3
VSTD-McClure-2006
p2818
sg5
S'PMC2018826'
p2819
sg7
g2815
sg9
V16954124.xml
p2820
sa(dp2821
g3
VSTD-Binnie-2007
p2822
sg5
S'PMC1871574'
p2823
sg7
VCD008286 v. 3.0 Combined pharmacotherapy and behavioural interventions for smoking cessation.rm5
p2824
sg9
V17475005.xml
p2825
sa(dp2826
g3
VSTD-_x00c5_gren-2011
p2827
sg5
S'PMC3233272'
p2828
sg7
VCD006133 v. 5.0 Steroidal contraceptives effect on carbohydrate metabolism in women without diabetes mellitus.rm5
p2829
sg9
V22066891.xml
p2830
sa(dp2831
g3
VSTD-Bennell-2010
p2832
sg5
S'PMC2830179'
p2833
sg7
VCD008618 v. 2.0 Exercise for improving outcomes after osteoporotic vertebral fracture.rm5
p2834
sg9
V20163739.xml
p2835
sa(dp2836
g3
VSTD-Morgan-2010
p2837
sg5
S'PMC3639680'
p2838
sg7
VCD003188 v. 15.3 Bisphosphonates in multiple myeloma a network meta-analysis.rm5
p2839
sg9
V21131037.xml
p2840
sa(dp2841
g3
VSTD-Jepson-2010
p2842
sg5
S'PMC2944371'
p2843
sg7
VMR000028 v. 2.4 How effects on health equity are assessed in systematic reviews of interventions.rm5
p2844
sg9
V20825660.xml
p2845
sa(dp2846
g3
VSTD-Bambra-2010
p2847
sg5
S'PMC2921286'
p2848
sg7
g2844
sg9
V19692738.xml
p2849
sa(dp2850
g3
VSTD-Darmstadt-2009
p2851
sg5
S'PMC2679412'
p2852
sg7
g2844
sg9
V19426469.xml
p2853
sa(dp2854
g3
VSTD-Main-2008
p2855
sg5
S'PMC2412872'
p2856
sg7
g2844
sg9
V18505545.xml
p2857
sa(dp2858
g3
VSTD-Yakoob-2009
p2859
sg5
S'PMC2679409'
p2860
sg7
g2844
sg9
V19426466.xml
p2861
sa(dp2862
g3
VSTD-Menezes-2009
p2863
sg5
S'PMC2679410'
p2864
sg7
g2844
sg9
V19426467.xml
p2865
sa(dp2866
g3
VSTD-Haws-2009
p2867
sg5
S'PMC2679411'
p2868
sg7
g2844
sg9
V19426468.xml
p2869
sa(dp2870
g3
VSTD-Shea-2009
p2871
sg5
S'PMC3226237'
p2872
sg7
g2844
sg9
V19828063.xml
p2873
sa(dp2874
g3
VSTD-Barros-2010
p2875
sg5
S'PMC2841444'
p2876
sg7
g2844
sg9
V20233384.xml
p2877
sa(dp2878
g3
VSTD-Collins-2008a
p2879
sg5
S'PMC2572211'
p2880
sg7
VCD008402 v. 2.0 Foot orthoses for patellofemoral pain in adults.rm5
p2881
sg9
V18952682.xml
p2882
sa(dp2883
g3
VSTD-Yeka-2007-UGA
p2884
sg5
S'PMC2405936'
p2885
sg7
VCD007483 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated malaria.rm5
p2886
sg9
V18545692.xml
p2887
sa(dp2888
g3
VSTD-Van-den-Broek-2004-ZAR
p2889
sg5
S'PMC1697822'
p2890
sg7
g2886
sg9
V17125496.xml
p2891
sa(dp2892
g3
VSTD-Yeka-2004-UGA
p2893
sg5
S'PMC1181876'
p2894
sg7
g2886
sg9
V16033307.xml
p2895
sa(dp2896
g3
VSTD-Faye-2003-SEN
p2897
sg5
S'PMC1919387'
p2898
sg7
g2886
sg9
V17570848.xml
p2899
sa(dp2900
g3
VSTD-Grande-2005-PER
p2901
sg5
S'PMC2040506'
p2902
sg7
g2886
sg9
V17971864.xml
p2903
sa(dp2904
g3
VSTD-Mukhtar-2005-SDN
p2905
sg5
S'PMC1940006'
p2906
sg7
g2886
sg9
V17631681.xml
p2907
sa(dp2908
g3
VSTD-Kobbe-2007-GHA
p2909
sg5
S'PMC2625364'
p2910
sg7
g2886
sg9
V19099594.xml
p2911
sa(dp2912
g3
VSTD-Kamya-2006-UGA
p2913
sg5
S'PMC1876597'
p2914
sg7
g2886
sg9
V17525792.xml
p2915
sa(dp2916
g3
VSTD-Mens-2007-KEN
p2917
sg5
S'PMC2600646'
p2918
sg7
g2886
sg9
V19017387.xml
p2919
sa(dp2920
g3
VSTD-Bonnet-2004-GIN
p2921
sg5
S'PMC1868032'
p2922
sg7
g2886
sg9
V17477865.xml
p2923
sa(dp2924
g3
VSTD-Bukirwa-2005-UGA
p2925
sg5
S'PMC1488893'
p2926
sg7
g2886
sg9
V16871329.xml
p2927
sa(dp2928
g3
VSTD-Hutagalung-2002-THA
p2929
sg5
S'PMC1261533'
p2930
sg7
g2886
sg9
V16179089.xml
p2931
sa(dp2932
g3
VSTD-Menard-2006-MDG
p2933
sg5
S'PMC1887535'
p2934
sg7
g2886
sg9
V17519010.xml
p2935
sa(dp2936
g3
VSTD-Owusu_x002d_Agyei-2006-GHA
p2937
sg5
S'PMC2430614'
p2938
sg7
g2886
sg9
V18575626.xml
p2939
sa(dp2940
g3
VSTD-Kayentao-2006-MLI
p2941
sg5
S'PMC2631542'
p2942
sg7
g2886
sg9
V19128455.xml
p2943
sa(dp2944
g3
VSTD-Sangdee-2002-_x002a_
p2945
sg5
S'PMC102323'
p2946
sg7
VCD001977 v. 8.0 Acupuncture for peripheral joint osteoarthritis.rm5
p2947
sg9
V11914160.xml
p2948
sa(dp2949
g3
VSTD-Sangdee-2002-_x002a__x002a_
p2950
sg5
S'PMC102323'
p2951
sg7
g2947
sg9
V11914160.xml
p2952
sa(dp2953
g3
VSTD-Assadi-2003
p2954
sg5
S'PMC293465'
p2955
sg7
VCD007775 v. 2.0 Pharmacological therapies for maintenance treatments of opium dependence.rm5
p2956
sg9
V14624703.xml
p2957
sa(dp2958
g3
VSTD-Nachum-2010
p2959
sg5
S'PMC2988803'
p2960
sg7
VCD006794 v. 5.0 Early amniotomy and early oxytocin for prevention of or therapy for delay in first stage spontaneo.rm5
p2961
sg9
V21054896.xml
p2962
sa(dp2963
g3
VSTD-Arun-2008
p2964
sg5
S'PMC2772000'
p2965
sg7
VCD010398 v. 1.2 The effect of pharmacist-provided non-dispensing services on patient outcomes health service utilis.rm5
p2966
sg9
V19902034.xml
p2967
sa(dp2968
g3
VSTD-Zwarenstein-2007
p2969
sg5
S'PMC2200659'
p2970
sg7
g2966
sg9
V17892588.xml
p2971
sa(dp2972
g3
VSTD-Quadri-1980
p2973
sg5
S'PMC3013310'
p2974
sg7
VCD004186 v. 10.0 Amitriptyline for depression.rm5
p2975
sg9
V22058460.xml
p2976
sa(dp2977
g3
VSTD-Avril-1997
p2978
sg5
S'PMC2223779'
p2979
sg7
VCD003412 v. 8.0 Interventions for basal cell carcinoma of the skin.rm5
p2980
sg9
V9218740.xml
p2981
sa(dp2982
g3
VSTD-Nafisi-2006
p2983
sg5
S'PMC1764008'
p2984
sg7
VCD000331 v. 10.2 Epidural versus non-epidural or no analgesia in labour.rm5
p2985
sg9
V17176461.xml
p2986
sa(dp2987
g3
VSTD-Zehnder-2010
p2988
sg5
S'PMC2841102'
p2989
sg7
VCD003380 v. 12.1 Psychological and educational interventions for preventing depression in children and adolescents.rm5
p2990
sg9
V20181120.xml
p2991
sa(dp2992
g3
VSTD-Ghana-2009
p2993
sg5
S'PMC2928084'
p2994
sg7
VCD000230 v. 7.7 Zinc supplementation for improving pregnancy and infant outcome.rm5
p2995
sg9
V19902797.xml
p2996
sa(dp2997
g3
VSTD-Kapoor-1996
p2998
sg5
S'PMC2443081'
p2999
sg7
VCD003327 v. 5.0 Surgical versus endoscopic treatment of bile duct stones.rm5
p3000
sg9
V8725454.xml
p3001
sa(dp3002
g3
VSTD-Yip-2011
p3003
sg5
S'PMC3221969'
p3004
sg7
VCD005207 v. 9.0 Colony stimulating factors (including erythropoietin granulocyte colony stimulating factor and anal.rm5
p3005
sg9
V21269484.xml
p3006
sa(dp3007
g3
VSTD-Matsumoto-2002
p3008
sg5
S'PMC2375187'
p3009
sg7
VCD007814 v. 2.0 Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer.rm5
p3010
sg9
V11870500.xml
p3011
sa(dp3012
g3
VSTD-LOTUS-Trial-2008
p3013
sg5
S'PMC2565581'
p3014
sg7
VCD003243 v. 6.0 Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults.rm5
p3015
sg9
V18469091.xml
p3016
sa(dp3017
g3
VSTD-Bernitz-2011
p3018
sg5
S'PMC3187863'
p3019
sg7
VCD000012 v. 10.0 Alternative versus conventional institutional settings for birth.rm5
p3020
sg9
V21749629.xml
p3021
sa(dp3022
g3
VSTD-Scalambrino-1989
p3023
sg5
S'PMC1852268'
p3024
sg7
VCD001067 v. 9.0 Antibiotic regimens for endometritis after delivery.rm5
p3025
sg9
V12839630.xml
p3026
sa(dp3027
g3
VSTD-Chatwani-1997
p3028
sg5
S'PMC2364549'
p3029
sg7
g3025
sg9
V18476152.xml
p3030
sa(dp3031
g3
VSTD-Chatwani-1995
p3032
sg5
S'PMC2364413'
p3033
sg7
g3025
sg9
V18475417.xml
p3034
sa(dp3035
g3
VSTD-Roy-2003
p3036
sg5
S'PMC1852268'
p3037
sg7
g3025
sg9
V12839630.xml
p3038
sa(dp3039
g3
VSTD-van-der-Roer-2008
p3040
sg5
S'PMC2527421'
p3041
sg7
VCD002014 v. 8.0 Behavioural treatment for chronic low-back pain.rm5
p3042
sg9
V18663487.xml
p3043
sa(dp3044
g3
VSTD-Nakakura-2012
p3045
sg5
S'PMC3299559'
p3046
sg7
VCD006132 v. 5.2 Interventions for improving adherence to ocular hypotensive therapy.rm5
p3047
sg9
V22419858.xml
p3048
sa(dp3049
g3
VSTD-Lazo-2010
p3050
sg5
S'PMC2945152'
p3051
sg7
VCD003619 v. 6.0 Weight reduction for non-alcoholic fatty liver disease.rm5
p3052
sg9
V20664019.xml
p3053
sa(dp3054
g3
VSTD-Harms-2008
p3055
sg5
S'PMC2373885'
p3056
sg7
VCD008530 v. 2.0 Antibiotic therapy for preventing infections in patients with acute stroke.rm5
p3057
sg9
V18478129.xml
p3058
sa(dp3059
g3
VSTD-Begley-2008
p3060
sg5
S'PMC2443289'
p3061
sg7
VCD007496 v. 2.0 Male circumcision for prevention of homosexual acquisition of HIV in men.rm5
p3062
sg9
V18628946.xml
p3063
sa(dp3064
g3
VSTD-McDaid-2010
p3065
sg5
S'PMC3010905'
p3066
sg7
g3062
sg9
V20595141.xml
p3067
sa(dp3068
g3
VSTD-Lane-2011
p3069
sg5
S'PMC2888758'
p3070
sg7
g3062
sg9
V19662523.xml
p3071
sa(dp3072
g3
VSTD-Abeku-2008a
p3073
sg5
S'PMC2571107'
p3074
sg7
VCD008122 v. 4.0 Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.rm5
p3075
sg9
V18834523.xml
p3076
sa(dp3077
g3
VSTD-Abeku-2008b
p3078
sg5
S'PMC2571107'
p3079
sg7
g3075
sg9
V18834523.xml
p3080
sa(dp3081
g3
VSTD-Msellem-2009
p3082
sg5
S'PMC2667629'
p3083
sg7
g3075
sg9
V19399156.xml
p3084
sa(dp3085
g3
VSTD-Bharti-2008
p3086
sg5
S'PMC2478667'
p3087
sg7
g3075
sg9
V18620560.xml
p3088
sa(dp3089
g3
VSTD-Arezzo-2008
p3090
sg5
S'PMC2565674'
p3091
sg7
VCD007076 v. 5.0 Pregabalin for acute and chronic pain in adults.rm5
p3092
sg9
V18796160.xml
p3093
sa(dp3094
g3
VSTD-Choo-2008
p3095
sg5
S'PMC2680337'
p3096
sg7
VCD005429 v. 5.0 Which anticholinergic drug for overactive bladder symptoms in adults.rm5
p3097
sg9
V19143854.xml
p3098
sa(dp3099
g3
VSTD-L-_x002d_-LEAD-1-Marre-2009
p3100
sg5
S'PMC2871176'
p3101
sg7
VCD006423 v. 4.0 Glucagon-like peptide analogues for type 2 diabetes mellitus.rm5
p3102
sg9
V19317822.xml
p3103
sa(dp3104
g3
VSTD-Lixi-_x002d_-Ratner-2010
p3105
sg5
S'PMC3068287'
p3106
sg7
g3102
sg9
V20722676.xml
p3107
sa(dp3108
g3
VSTD-T-_x002d_-Nauck-2009
p3109
sg5
S'PMC2699710'
p3110
sg7
g3102
sg9
V19366970.xml
p3111
sa(dp3112
g3
VSTD-A-_x002d_-Rosenstock-2009
p3113
sg5
S'PMC2752910'
p3114
sg7
g3102
sg9
V19592625.xml
p3115
sa(dp3116
g3
VSTD-L-_x002d_-LEAD-2-Nauck-2009
p3117
sg5
S'PMC2606836'
p3118
sg7
g3102
sg9
V18931095.xml
p3119
sa(dp3120
g3
VSTD-L-_x002d_-LEAD-5-Russell_x002d_J-2009
p3121
sg5
S'PMC2744824'
p3122
sg7
g3102
sg9
V19688338.xml
p3123
sa(dp3124
g3
VSTD-L-_x002d_-LEAD-4-Zinman-2009
p3125
sg5
S'PMC2699702'
p3126
sg7
g3102
sg9
V19289857.xml
p3127
sa(dp3128
g3
VSTD-T_x002d_-Ratner-2010
p3129
sg5
S'PMC2948428'
p3130
sg7
g3102
sg9
V20536952.xml
p3131
sa(dp3132
g3
VSTD-Feste-2000
p3133
sg5
S'PMC3015351'
p3134
sg7
VCD006583 v. 5.0 Laparoscopic entry techniques.rm5
p3135
sg9
V10772522.xml
p3136
sa(dp3137
g3
VSTD-Venkatesh-2007
p3138
sg5
S'PMC3015718'
p3139
sg7
g3135
sg9
V17761080.xml
p3140
sa(dp3141
g3
VSTD-Wells-2004
p3142
sg5
S'PMC2364768'
p3143
sg7
VCD007672 v. 2.3 Interventions to improve continuity of care in the follow-up of patients with cancer.rm5
p3144
sg9
V15238983.xml
p3145
sa(dp3146
g3
VSTD-King-2009
p3147
sg5
S'PMC2634705'
p3148
sg7
g3144
sg9
V19107130.xml
p3149
sa(dp3150
g3
VSTD-Wattchow-2006
p3151
sg5
S'PMC2361245'
p3152
sg7
g3144
sg9
V16622437.xml
p3153
sa(dp3154
g3
VSTD-Hanks-2002
p3155
sg5
S'PMC2364271'
p3156
sg7
g3144
sg9
V12232756.xml
p3157
sa(dp3158
g3
VSTD-Hochreiter-2009
p3159
sg5
S'PMC2717450'
p3160
sg7
VCD007498 v. 3.5 Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.rm5
p3161
sg9
V19493352.xml
p3162
sa(dp3163
g3
VSTD-Brown-2001
p3164
sg5
S'PMC2375236'
p3165
sg7
VCD004565 v. 3.0 Interventions before consultations for helping patients address their information needs.rm5
p3166
sg9
V11720460.xml
p3167
sa(dp3168
g3
VSTD-Brown-1999
p3169
sg5
S'PMC2363012'
p3170
sg7
g3166
sg9
V10390003.xml
p3171
sa(dp3172
g3
VSTD-Ramakrishna-2008
p3173
sg5
S'PMC2217593'
p3174
sg7
VCD006519 v. 3.0 Polymer-based oral rehydration solution for treating acute watery diarrhoea.rm5
p3175
sg9
V18270575.xml
p3176
sa(dp3177
g3
VSTD-Juvenile-2009
p3178
sg5
S'PMC2945155'
p3179
sg7
VCD008101 v. 3.0 Continuous glucose monitoring systems for type 1 diabetes mellitus.rm5
p3180
sg9
V20696865.xml
p3181
sa(dp3182
g3
VSTD-Raccah-2009
p3183
sg5
S'PMC2782985'
p3184
sg7
g3180
sg9
V19767384.xml
p3185
sa(dp3186
g3
VSTD-Battelino-2011
p3187
sg5
S'PMC3064030'
p3188
sg7
g3180
sg9
V21335621.xml
p3189
sa(dp3190
g3
VSTD-Luckner-2006
p3191
sg5
S'PMC1550871'
p3192
sg7
VCD003709 v. 5.0 Vasopressors for hypotensive shock.rm5
p3193
sg9
V16542484.xml
p3194
sa(dp3195
g3
VSTD-Morelli-2009
p3196
sg5
S'PMC2750187'
p3197
sg7
g3193
sg9
V19664253.xml
p3198
sa(dp3199
g3
VSTD-Fraser-1993
p3200
sg5
S'PMC1968186'
p3201
sg7
VCD003367 v. 9.0 Antitumour antibiotic containing regimens for metastatic breast cancer.rm5
p3202
sg9
V8431375.xml
p3203
sa(dp3204
g3
VSTD-Harper_x002d_Wynne-1999
p3205
sg5
S'PMC2362871'
p3206
sg7
g3202
sg9
V10496359.xml
p3207
sa(dp3208
g3
VSTD-Karabay-2004
p3209
sg5
S'PMC459220'
p3210
sg7
VCD007179 v. 3.0 Antibiotics for treating human brucellosis.rm5
p3211
sg9
V15214959.xml
p3212
sa(dp3213
g3
VSTD-Lumley-2006
p3214
sg5
S'PMC1479326'
p3215
sg7
VCD001134 v. 9.0 Psychosocial and psychological interventions for preventing postpartum depression.rm5
p3216
sg9
V16483383.xml
p3217
sa(dp3218
g3
VSTD-Dennis-2009
p3219
sg5
S'PMC2628301'
p3220
sg7
g3216
sg9
V19147637.xml
p3221
sa(dp3222
g3
VSTD-Gilbert-2008
p3223
sg5
S'PMC2292251'
p3224
sg7
VCD007844 v. 3.0 Behavioral interventions to promote condom use among women living with HIV.rm5
p3225
sg9
V18431475.xml
p3226
sa(dp3227
g3
VSTD-Girish-2003
p3228
sg5
S'PMC2951534'
p3229
sg7
VCD000076 v. 11.0 Electroconvulsive therapy for schizophrenia.rm5
p3230
sg9
V21206808.xml
p3231
sa(dp3232
g3
VSTD-Agarwal-1985
p3233
sg5
S'PMC3011123'
p3234
sg7
g3230
sg9
V21927109.xml
p3235
sa(dp3236
g3
VSTD-Bagadia-1981
p3237
sg5
S'PMC3012902'
p3238
sg7
g3230
sg9
V22058556.xml
p3239
sa(dp3240
g3
VSTD-Janakiramiah-1981
p3241
sg5
S'PMC3012948'
p3242
sg7
g3230
sg9
V22058544.xml
p3243
sa(dp3244
g3
VSTD-Jordan-2003
p3245
sg5
S'PMC1241771'
p3246
sg7
VCD006047 v. 5.4 Household interventions for preventing domestic lead exposure in children.rm5
p3247
sg9
V14644671.xml
p3248
sa(dp3249
g3
VSTD-Symonds-1996
p3250
sg5
S'PMC2074575'
p3251
sg7
VCD000978 v. 13.0 Interventions for preventing oral mucositis for patients with cancer receiving treatment.rm5
p3252
sg9
V8688343.xml
p3253
sa(dp3254
g3
VSTD-Stokman-2003
p3255
sg5
S'PMC2376383'
p3256
sg7
g3252
sg9
V12671696.xml
p3257
sa(dp3258
g3
VSTD-Jebb-1994
p3259
sg5
S'PMC2033386'
p3260
sg7
g3252
sg9
V7917930.xml
p3261
sa(dp3262
g3
VSTD-Mills-1988
p3263
sg5
S'PMC2246575'
p3264
sg7
g3252
sg9
V3390377.xml
p3265
sa(dp3266
g3
VSTD-Hartmann-2001
p3267
sg5
S'PMC2363753'
p3268
sg7
g3252
sg9
V11161394.xml
p3269
sa(dp3270
g3
VSTD-START-A-2008
p3271
sg5
S'PMC2323709'
p3272
sg7
VCD003860 v. 8.4 Fraction size in radiation treatment for breast conservation in early breast cancer.rm5
p3273
sg9
V18356109.xml
p3274
sa(dp3275
g3
VSTD-Vargas-2005
p3276
sg5
S'PMC1269449'
p3277
sg7
VCD008328 v. 2.8 Airway clearance techniques for chronic obstructive pulmonary disease.rm5
p3278
sg9
V16137351.xml
p3279
sa(dp3280
g3
VSTD-N_x00e1_polis-2011
p3281
sg5
S'PMC3071998'
p3282
sg7
VCD009419 v. 2.0 Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.rm5
p3283
sg9
V21552662.xml
p3284
sa(dp3285
g3
VSTD-Nilsson-2009
p3286
sg5
S'PMC2760502'
p3287
sg7
VCD005595 v. 3.0 Rehabilitation for ankle fractures in adults.rm5
p3288
sg9
V19781053.xml
p3289
sa(dp3290
g3
VSTD-Wahl-2008
p3291
sg5
S'PMC2573879'
p3292
sg7
VCD004974 v. 9.0 Immunostimulants for preventing respiratory tract infection in children.rm5
p3293
sg9
V18831749.xml
p3294
sa(dp3295
g3
VSTD-Mansour-2011
p3296
sg5
S'PMC3233274'
p3297
sg7
VCD004425 v. 10.0 Combined oral contraceptive pills for treatment of acne.rm5
p3298
sg9
V21995590.xml
p3299
sa(dp3300
g3
VSTD-Hwang-2008
p3301
sg5
S'PMC2615347'
p3302
sg7
VCD008465 v. 2.0 Exercise interventions on health-related quality of life for people with cancer during active treatm.rm5
p3303
sg9
V18581595.xml
p3304
sa(dp3305
g3
VSTD-Vadiraja-2009b
p3306
sg5
S'PMC2933732'
p3307
sg7
g3303
sg9
V20842268.xml
p3308
sa(dp3309
g3
VSTD-Adamsen-2009
p3310
sg5
S'PMC2762035'
p3311
sg7
g3303
sg9
V19826172.xml
p3312
sa(dp3313
g3
VSTD-Oh-2010
p3314
sg5
S'PMC2826100'
p3315
sg7
g3303
sg9
V19880433.xml
p3316
sa(dp3317
g3
VSTD-Voerman-2007
p3318
sg5
S'PMC1915628'
p3319
sg7
VCD008160 v. 3.0 Workplace interventions for neck pain in workers.rm5
p3320
sg9
V17260162.xml
p3321
sa(dp3322
g3
VSTD-Hwang-2008
p3323
sg5
S'PMC2615347'
p3324
sg7
VCD005211 v. 6.0 Exercise interventions for upper-limb dysfunction due to breast cancer treatment.rm5
p3325
sg9
V18581595.xml
p3326
sa(dp3327
g3
VSTD-Carey-2005
p3328
sg5
S'PMC547907'
p3329
sg7
VCD005473 v. 3.0 Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.rm5
p3330
sg9
V15667657.xml
p3331
sa(dp3332
g3
VSTD-Rabius-2008
p3333
sg5
S'PMC2630842'
p3334
sg7
VCD007078 v. 6.0 Internet-based interventions for smoking cessation.rm5
p3335
sg9
V19033146.xml
p3336
sa(dp3337
g3
VSTD-Stoddard-2008
p3338
sg5
S'PMC2630832'
p3339
sg7
g3335
sg9
V19097974.xml
p3340
sa(dp3341
g3
VSTD-Etter-2005
p3342
sg5
S'PMC1550632'
p3343
sg7
g3335
sg9
V15829474.xml
p3344
sa(dp3345
g3
VSTD-McKay-2008
p3346
sg5
S'PMC2630830'
p3347
sg7
g3335
sg9
V19017582.xml
p3348
sa(dp3349
g3
VSTD-Brendryen-2008a
p3350
sg5
S'PMC2630841'
p3351
sg7
g3335
sg9
V19087949.xml
p3352
sa(dp3353
g3
VSTD-Hwang-2008
p3354
sg5
S'PMC2615347'
p3355
sg7
VCD006145 v. 6.0 Exercise for the management of cancer-related fatigue in adults.rm5
p3356
sg9
V18581595.xml
p3357
sa(dp3358
g3
VSTD-Adamsen-2009
p3359
sg5
S'PMC2762035'
p3360
sg7
g3356
sg9
V19826172.xml
p3361
sa(dp3362
g3
VSTD-Oh-2010
p3363
sg5
S'PMC2826100'
p3364
sg7
g3356
sg9
V19880433.xml
p3365
sa(dp3366
g3
VSTD-Lepere-2000
p3367
sg5
S'PMC3015374'
p3368
sg7
VCD004703 v. 6.0 Transabdominal pre-peritoneal (TAPP) vs totally extraperitoneal (TEP) laparoscopic techniques for in.rm5
p3369
sg9
V10917122.xml
p3370
sa(dp3371
g3
VSTD-Bruggemann-2007
p3372
sg5
S'PMC1936417'
p3373
sg7
VCD003766 v. 11.2 Continuous support for women during childbirth.rm5
p3374
sg9
V17612408.xml
p3375
sa(dp3376
g3
VSTD-Cascinu-1995
p3377
sg5
S'PMC2033463'
p3378
sg7
VCD003445 v. 8.0 Supportive care for patients with gastrointestinal cancer.rm5
p3379
sg9
V7819058.xml
p3380
sa(dp3381
g3
VSTD-Kikuchi-2006
p3382
sg5
S'PMC2360636'
p3383
sg7
VCD005004 v. 4.0 Green tea (Camellia sinensis) for the prevention of cancer.rm5
p3384
sg9
V16804523.xml
p3385
sa(dp3386
g3
VSTD-Hoshiyama-2002
p3387
sg5
S'PMC2364221'
p3388
sg7
g3384
sg9
V12177800.xml
p3389
sa(dp3390
g3
VSTD-Suzuki-2004
p3391
sg5
S'PMC2409667'
p3392
sg7
g3384
sg9
V15054454.xml
p3393
sa(dp3394
g3
VSTD-Key-1999
p3395
sg5
S'PMC2374337'
p3396
sg7
g3384
sg9
V10584890.xml
p3397
sa(dp3398
g3
VSTD-Li-2008
p3399
sg5
S'PMC2567088'
p3400
sg7
g3384
sg9
V18766189.xml
p3401
sa(dp3402
g3
VSTD-Wright-2008
p3403
sg5
S'PMC2440307'
p3404
sg7
VCD007275 v. 2.0 Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.rm5
p3405
sg9
V18261131.xml
p3406
sa(dp3407
g3
VSTD-Baharvand-2010
p3408
sg5
S'PMC3232086'
p3409
sg7
VCD001973 v. 9.0 Interventions for treating oral mucositis for patients with cancer receiving treatment.rm5
p3410
sg9
V22615593.xml
p3411
sa(dp3412
g3
VSTD-Osman-2010
p3413
sg5
S'PMC2922723'
p3414
sg7
VCD006842 v. 3.0 Oscillating devices for airway clearance in people with cystic fibrosis.rm5
p3415
sg9
V19703826.xml
p3416
sa.